10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q/A

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                      .

Commission file number: 001-36154

SURGICAL CARE AFFILIATES, INC.

(Exact name of registrant as specified in its charter)

Delaware	20-8740447
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
520 Lake Cook Road, Suite 250 Deerfield, IL	60015
(Address of principal executive offices)	(Zip Code)

(847) 236-0921

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ¨    No  x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	x	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class of Common Stock	Outstanding at November 13, 2013
Common stock, $0.01 par value	38,142,861 shares

EXPLANATORY NOTE

The sole purpose of this Amendment No. 1 to the Quarterly Report of Surgical Care Affiliates, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2013, filed with the Securities and Exchange Commission on November 15, 2013 (the “Form 10-Q”), is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 to this report provides the Interactive Data Files for the condensed consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language). As permitted by Rule 405(a)(2)(ii) of Regulation S-T, Exhibit 101 was required to be furnished by amendment within 30 days of the original filing date of the Form 10-Q.

Other than the aforementioned, no other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.

1

PART II — OTHER INFORMATION

Item 6. Exhibits

Exhibit Number	Exhibit Description
3.1	Certificate of Incorporation of Surgical Care Affiliates, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 4, 2013)
3.2	By-Laws of Surgical Care Affiliates, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 4, 2013)
31.1*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 and Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 and Section 302 of the Sarbanes-Oxley Act of 2002
32.1*	Certification by Chief Executive Officer pursuant to 18 USC. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS**	XBRL Instance Document
101.SCH**	XBRL Taxonomy Extension Schema Document
101.CAL**	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF**	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB**	XBRL Taxonomy Extension Label Linkbase Document
101.PRE**	XBRL Taxonomy Extension Presentation Linkbase Document

* Previously filed with the Company’s Form 10-Q for the period ended September 30, 2013, which was filed with the Securities and Exchange Commission on November 15, 2013.

** Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	SURGICAL CARE AFFILIATES, INC. (Registrant)
Date: December 13, 2013	/s/ Andrew Hayek
	Andrew Hayek President and Chief Executive Officer
Date: December 13, 2013	/s/ Peter Clemens
	Peter Clemens Executive Vice President and Chief Financial Officer

3

XML

Equity-Based Compensation

9 Months Ended

Sep. 30, 2013

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Equity-Based Compensation

NOTE 9 — EQUITY-BASED COMPENSATION

In conjunction with our conversion to a Delaware corporation on October 30, 2013 (see Note 1), every 10.25 outstanding membership units of ASC Acquisition LLC were converted into one share of common stock of Surgical Care Affiliates, Inc., and options to purchase membership units of ASC Acquisition LLC were converted into options to purchase shares of common stock of Surgical Care Affiliates, Inc. at a ratio of 10.25 membership units of ASC Acquisition LLC underlying such options to each one share of common stock of Surgical Care Affiliates, Inc. underlying such converted options. In connection with the conversion, the exercise prices of such converted options were adjusted accordingly. In addition, every 10.25 outstanding restricted equity units of ASC Acquisition LLC were converted into one restricted equity share of Surgical Care Affiliates, Inc. All information in this Quarterly Report on Form 10-Q is presented giving effect to the conversion.

On September 16, 2013, our board of directors accelerated the vesting of 806,303 performance-based options. This modification was a “probable-to-probable” modification under the authoritative guidance. As a result of the acceleration, the Company recognized $0.8 million of additional stock-based compensation expense in the three-months ended September 30, 2013. The additional expense represents the incremental fair value as a result of the modification.

Also on September 16, 2013, our board of directors resolved to pay a cash bonus of $2.46 per vested option and adjust downward the exercise price of all unvested options by approximately $2.46 per unvested option. As such the Company recorded additional compensation expense of $4.6 million during the three- and nine-months ended September 30, 2013. We will record stock-based compensation expense over the remaining vesting periods related to the adjustment to unvested options. This modification was a “probable-to-probable” modification under the authoritative guidance. We will record $1.6 million of additional stock-based compensation expense over remaining vesting periods of the modified options.

Information pertaining to share-based activity during the three- and nine- months ended September 30, 2013 and 2012 was as follows (in thousands):

	Three-months Ended				Nine-months Ended
	September 30,				September 30,
	2013		2012		2013		2012
Stock-based compensation expense	$	1,664	$	459	$	2,093	$	1,260

As of September 30, 2013, the Company had total unrecognized compensation cost of approximately $7.9 million related to non-vested awards, which the Company expects to recognize through 2017 and over a weighted average period of 2.7 years.

A summary of the status of non-vested restricted shares at September 30, 2013 and changes during the nine-months ended September 30, 2013 is as follows:

	Number of Shares			Weighted Average Grant Price
Non-vested shares at December 31, 2012		19,712		$	10.63
Shares granted		51,417			22.93
Shares vested		(16,685	)		10.63
Non-vested shares at September 30, 2013		54,444		$	22.93

A summary of stock option activity for the nine-months ended September 30, 2013 is summarized as follows:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)
Outstanding at December 31, 2012		2,387,646	$	11.00		5.72
Outstanding at September 30, 2013		2,996,101	$	11.27		5.89
Vested at September 30, 2013		1,958,827	$	11.30		5.72

XML

Fair Value of Financial Instruments - Schedule of Fair Values of Our Assets and Liabilities that are Measured on Recurring Basis (Detail) (Fair Value, Measurements, Recurring [Member], Income Approach [Member], USD $) In Millions, unless otherwise specified	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Assets
Total assets	$ 1.7
Liabilities
Total liabilities	3.3	6.1
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Assets
Total assets
Liabilities
Total liabilities
Significant Other Observable Inputs (Level 2) [Member]
Assets
Total assets
Liabilities
Total liabilities	3.3	6.1
Significant Unobservable Inputs (Level 3) [Member]
Assets
Total assets	1.7
Liabilities
Total liabilities
Other current liabilities [Member]
Liabilities
Total liabilities		2.2
Fair Value Measurement, Valuation Technique	Income approach (I)	Income approach (I)
Other current liabilities [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Liabilities
Total liabilities
Other current liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member]
Liabilities
Total liabilities		2.2
Other current liabilities [Member] | Significant Unobservable Inputs (Level 3) [Member]
Liabilities
Total liabilities
Other long-term liabilities [Member]
Liabilities
Total liabilities	3.3	3.9
Fair Value Measurement, Valuation Technique	Income approach (I)	Income approach (I)
Other long-term liabilities [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Liabilities
Total liabilities
Other long-term liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member]
Liabilities
Total liabilities	3.3	3.9
Other long-term liabilities [Member] | Significant Unobservable Inputs (Level 3) [Member]
Liabilities
Total liabilities
Other long-term assets [Member]
Assets
Total assets	1.7
Liabilities
Fair Value Measurement, Valuation Technique	Income approach (I)
Other long-term assets [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Assets
Total assets
Other long-term assets [Member] | Significant Other Observable Inputs (Level 2) [Member]
Assets
Total assets
Other long-term assets [Member] | Significant Unobservable Inputs (Level 3) [Member]
Assets
Total assets	$ 1.7

XML

Condensed Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net operating revenues:
Net patient revenues	$ 177,686	$ 173,636	$ 548,685	$ 526,512
Management fee revenues	13,189	4,395	26,220	13,629
Other revenues	4,208	2,747	10,580	8,797
Total net operating revenues	195,083	180,778	585,485	548,938
Equity in net income of nonconsolidated affiliates	4,105	4,890	16,111	16,676
Operating expenses:
Salaries and benefits	74,788	59,153	202,189	180,112
Supplies	42,565	41,030	128,242	124,211
Other operating expenses	31,080	28,374	89,293	89,576
Depreciation and amortization	10,993	10,076	31,928	30,414
Occupancy costs	6,875	6,714	20,378	19,952
Provision for doubtful accounts	3,383	4,161	10,364	10,291
Impairment of intangible and long-lived assets				434
Loss (gain) on disposal of assets	269	(131)	339	(186)
Total operating expenses	169,953	149,377	482,733	454,804
Operating income	29,235	36,291	118,863	110,810
Interest expense	14,527	14,217	48,817	44,658
Loss from extinguishment of debt			3,800
Interest income	(50)	(14)	(167)	(235)
Loss on sale of investments	75		1,060	(2,001)
Income from continuing operations before income tax expense	14,683	22,088	65,353	68,388
Provision for income tax expense	5,728	3,992	10,163	8,664
Income from continuing operations	8,955	18,096	55,190	59,724
(Loss) income from discontinued operations, net of income tax expense	(255)	1,041	(4,237)	(4,113)
Net income	8,700	19,137	50,953	55,611
Less: Net income attributable to noncontrolling interests	(21,408)	(22,129)	(74,860)	(68,860)
Net loss attributable to Surgical Care Affiliates	$ (12,708)	$ (2,992)	$ (23,907)	$ (13,249)
Basic and diluted net loss per share attributable to Surgical Care Affiliates:
Continuing operations attributable to Surgical Care Affiliates	$ (0.41)	$ (0.14)	$ (0.67)	$ (0.32)
Discontinued operations attributable to Surgical Care Affiliates	$ (0.01)	$ 0.04	$ (0.12)	$ (0.12)
Net loss per share attributable to Surgical Care Affiliates	$ (0.42)	$ (0.10)	$ (0.79)	$ (0.44)
Basic and diluted weighted average shares outstanding	30,353	30,343	30,347	30,338

XML

Transactions, Deconsolidations and Closures

9 Months Ended

Sep. 30, 2013

Text Block [Abstract]

Transactions, Deconsolidations and Closures

NOTE 2 — TRANSACTIONS, DECONSOLIDATIONS AND CLOSURES

Acquisitions

In April 2013, we invested in an ASC for total consideration of $4.0 million. This ASC is consolidated (as part of the future JV, as further described in Note 3) as a VIE in which we are the primary beneficiary. The amounts recognized as of the acquisition date for each major class of assets and liabilities assumed are as follows:

Assets
Property and equipment	$	2,971
Goodwill		679
Intangible assets		350
Total assets	$	4,000
Liabilities
Total liabilities	$	—

In June 2013, we acquired 100% of the interest in Health Inventures, LLC (“HI”), a surgical and physician services company, for total consideration of $18.5 million. $9.6 million of the consideration was paid to the sellers in cash; the remaining amount, $8.9 million, was placed into escrow as contingent consideration. The amount payable as contingent consideration depends upon the successful continuation and/or renewal of certain management agreement contracts held by HI and, in the case of renewals, will be determined by comparing the contract revenue prior to renewal against the expected contract revenue after renewal. The undiscounted range of amounts that could be paid as contingent consideration is zero to $8.9 million. As of the acquisition date and September 30, 2013, approximately $7.2 million of contingent consideration was recognized. In the transaction, we acquired HI’s ownership interests in four ASCs and one surgical hospital and management agreements with 19 affiliated facilities.

The HI amounts recognized as of the acquisition date for each major class of assets and liabilities assumed are as follows:

Assets
Current assets
Cash and cash equivalents	$	1,179
Accounts receivable		2,130
Other current assets		400
Total current assets		3,709
Property and equipment		584
Goodwill		2,269
Intangible assets		7,605
Investment in and advances to nonconsolidated affiliates		4,360
Total assets	$	18,527
Liabilities
Current liabilities
Accounts payable and other current liabilities	$	1,742
Total current liabilities		1,742
Total liabilities	$	1,742

The HI goodwill and intangible assets are expected to be fully deductible for tax purposes. The HI purchase price allocation is preliminary and subject to adjustment.

Also during the nine-month period ended September 30, 2013, we acquired a noncontrolling interest in a surgery center in Newport Beach, California and acquired a management agreement with a surgery center in Fountain Valley, California for an immaterial amount of consideration.

Deconsolidations, Closures and Sale

During the nine-month period ended September 30, 2013, we completed two separate deconsolidation transactions. In one of these transactions, we sold a controlling equity interest, and transferred certain control rights, to a health system. We retained a noncontrolling interest in this affiliate. We received cash proceeds of approximately $2.1 million and recorded a pre-tax loss of approximately $1.6 million, which was primarily related to the revaluation of our remaining investment in this affiliate to fair value. The loss on this transaction is recorded in Loss (gain) on sale of investments in the accompanying condensed consolidated statements of operations. In the other transaction, we transferred certain control rights to partners in the entity. We retained a noncontrolling interest in this affiliate. We recorded a pre-tax loss of approximately $1.5 million, which was primarily related to the revaluation of our remaining investment in this affiliate to fair value. The loss on this transaction is recorded in Equity in net income of nonconsolidated affiliates in the accompanying condensed consolidated statements of operations.

During the nine-month period ended September 30, 2012, we completed one deconsolidation transaction. In the transaction, we sold a controlling equity interest in an ASC and transferred certain control rights to a health system. We retained a noncontrolling interest in this affiliate. We received cash proceeds of approximately $4.3 million and recorded a pre-tax gain of approximately $2.0 million, which was primarily related to the revaluation of our remaining investment in this affiliate to fair value. The gain on this transaction is recorded in Gain on sale of investments in the accompanying condensed consolidated statements of operations.

Fair values for the retained noncontrolling interests are primarily estimated based on third party valuations we have obtained in connection with such transactions and/or the amount of proceeds received for the controlling equity interest sold. Our continuing involvement as an equity method investor and manager of the facilities precludes classification of these transactions as discontinued operations.

During the nine-month period ended September 30, 2013, we closed one facility. We recorded a pre-tax loss of approximately $1.5 million as a result of the closure. The loss on the transaction is recorded in the Loss from discontinued operations, net of income tax in the accompanying condensed consolidated statements of operations.

During the nine-month period ended September 30, 2012, we closed two facilities. We recorded a pre-tax loss of approximately $3.2 million as a result of the closures. The loss on these transactions is recorded in the Loss from discontinued operations, net of income tax in the accompanying condensed consolidated statements of operations. We also wrote off approximately $2.2 million of goodwill related to one closure.

During the nine-month period ended September 30, 2012, we sold all of our interest in one ASC. We recorded a pre-tax gain of approximately $1.5 million as a result of the sale. The gain on this transaction is recorded in the Loss from discontinued operations, net of income tax in the accompanying condensed consolidated statements of operations.

XML

Description of Business (Tables)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Summary of Business Structure

We account for our 174 facilities as follows:

	AS OF SEPTEMBER 30, 2013
Consolidated facilities		86
Equity method facilities		61
Managed only facilities		27
Total facilities		174

XML

Equity-Based Compensation - Summary of Stock Option Activity (Detail) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Number of Options, Outstanding, Beginning Balance	2,387,646
Number of Options, Outstanding, Ending Balance	2,996,101	2,387,646
Number of options, vested	1,958,827
Weighted Average Exercise Price, Outstanding, Beginning Balance	$ 11.00
Weighted Average Exercise Price, Outstanding, Ending Balance	$ 11.27	$ 11.00
Weighted Average Exercise Price, Vested	$ 11.30
Weighted Average Remaining Contractual Term, Outstanding	5 years 10 months 21 days	5 years 8 months 19 days
Weighted Average Remaining Contractual Term, Vested	5 years 8 months 19 days

XML

Fair Value of Financial Instruments - Schedule of Quantitative Information Associated with Fair Value Measurement of Our Recurring Level 3 Inputs (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2013
Minimum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Retention period for each contract	12 months
Maximum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Retention period for each contract	18 months

XML

Income Taxes

9 Months Ended

Sep. 30, 2013

Income Tax Disclosure [Abstract]

Income Taxes

NOTE 10 — INCOME TAXES

The provision for income tax expense for the three-months ended September 30, 2013 includes the following: (1) current income tax expense of $0.2 million attributable to state income taxes of subsidiaries which have separate state tax filing requirements and (2) deferred income tax expense of $5.5 million attributable to the tax amortization of goodwill that is not amortized for book purposes.

The provision for income tax expense for the nine-months ended September 30, 2013 includes the following: (1) current income tax expense of $0.5 million attributable to state income taxes of subsidiaries which have separate state tax filing requirements and (2) deferred income tax expense of $9.7 million attributable to the tax amortization of goodwill that is not amortized for book purposes.

The provision for income tax expense for the three-months ended September 30, 2012 includes the following: (1) current income tax expense of $0.1 million attributable to state income taxes of subsidiaries which have separate state tax filing requirements and (2) deferred income tax expense of $3.9 million attributable to the tax amortization of goodwill that is not amortized for book purposes.

The provision for income tax expense for the nine-months ended September 30, 2012 includes the following: (1) current income tax expense of $0.3 million attributable to state income taxes of subsidiaries which have separate state tax filing requirements and (2) deferred income tax expense of $8.4 million attributable to the tax amortization of goodwill that is not amortized for book purposes.

We reduce our deferred income tax assets by a valuation allowance if, based on the weight of the available evidence, it is more likely than not that all or a portion of a deferred tax asset will not be realized. We currently have a full valuation allowance against net deferred tax assets, other than the deferred tax liability resulting from the amortization of goodwill, which is considered an indefinite-lived intangible. On a quarterly basis, we assess the likelihood of realization of our deferred tax assets considering all available evidence, both positive and negative. Our most recent operating performance, the scheduled reversal of temporary differences and our forecast of taxable income in future periods are important considerations in our assessment. Management has considered all positive and negative evidence available at this time and has concluded that a full valuation allowance continues to be appropriate as of September 30, 2013. We continue to closely monitor actual and forecasted earnings and, if there is a change in management’s assessment of the amount of deferred income tax assets that is realizable, adjustments to the valuation allowance will be made in future periods.

XML

Long-Term Debt - Summary of Applicable Margin for Each Portion of Credit Facility (Detail)	9 Months Ended
	Sep. 30, 2013
Base Rate Borrowings [Member] | Class B [Member] | Class B Revolving Credit Facility [Member]
Schedule Of Interest Rate [Line Items]
Applicable Margin on Borrowings	2.50%
Base Rate Borrowings [Member] | Class B [Member] | Term Loan [Member]
Schedule Of Interest Rate [Line Items]
Applicable Margin on Borrowings	3.00%
Base Rate Borrowings [Member] | Class C [Member] | Term Loan [Member]
Schedule Of Interest Rate [Line Items]
Applicable Margin on Borrowings, Description	2.00% or 2.25% (with a base rate floor of 2.00%) depending upon the total leverage ratio
Floor rate, Lower	2.00%
Floor rate, Higher	2.25%
Floor rate	2.00%
LIBOR Borrowings [Member] | Class B [Member] | Class B Revolving Credit Facility [Member]
Schedule Of Interest Rate [Line Items]
Applicable Margin on Borrowings	3.50%
LIBOR Borrowings [Member] | Class B [Member] | Term Loan [Member]
Schedule Of Interest Rate [Line Items]
Applicable Margin on Borrowings	4.00%
LIBOR Borrowings [Member] | Class C [Member] | Term Loan [Member]
Schedule Of Interest Rate [Line Items]
Applicable Margin on Borrowings, Description	3.00% or 3.25% (with a LIBOR floor of 1.00%) depending upon the total leverage ratio
Floor rate, Lower	3.00%
Floor rate, Higher	3.25%
Floor rate	1.00%

XML

Fair Value of Financial Instruments - Schedule of Roll-Forward of Recurring Fair Value Balance Used Level 3 Inputs (Detail) (Fair Value, Measurements, Recurring [Member], USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Fair Value, Measurements, Recurring [Member]
Fair Value Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]
Contingent Consideration, Beginning balance
Addition of contingent consideration asset	1.7
Contingent Consideration, Ending balance	$ 1.7

XML

Transactions, Deconsolidations and Closures - Summary of HI Amounts Recognized as of Acquisition Date for Each Major Class of Assets and Liabilities (Detail) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Apr. 30, 2013	Dec. 31, 2012	Jun. 30, 2013 Health Inventures, LLC [Member]
Current assets
Cash and cash equivalents				$ 1,179
Accounts receivable				2,130
Other current assets				400
Total current assets				3,709
Property and equipment		2,971		584
Goodwill	701,971	679	706,495	2,269
Intangible assets		350		7,605
Investment in and advances to nonconsolidated affiliates				4,360
Total assets		4,000		18,527
Current liabilities
Accounts payable and other current liabilities				1,742
Total current liabilities				1,742
Total liabilities				$ 1,742

XML

Goodwill (Tables)

9 Months Ended

Sep. 30, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Changes in Carrying Amount of Goodwill

The following table shows changes in the carrying amount of goodwill for the nine-months ended September 30, 2013:

Balance at December 31, 2012	$	706,495
Acquisitions (see Note 2)		2,983
Deconsolidation (see Note 2)		(7,351	)
Other		(156	)
Balance at September 30, 2013	$	701,971

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Schedule of Carrying Amounts and Classifications of Assets and Liabilities of Future Joint Venture

The carrying amounts and classifications of the assets and liabilities of the future JV, which are included in our September 30, 2013 and December 31, 2012 consolidated balance sheets, were as follows:

	SEPTEMBER 30, 2013		DECEMBER 31, 2012
Assets
Current assets
Accounts receivable, net	$	3,767	$	1,867
Other current assets		9,613		4,635
Total current assets		13,380		6,502
Property and equipment, net		12,630		5,630
Goodwill		12,831		12,265
Intangible assets		5,205		5,792
Total assets	$	44,046	$	30,189
Liabilities
Current liabilities
Accounts payable and other current liabilities	$	4,357	$	1,348
Total current liabilities		4,357		1,348
Other long-term liabilities		3,775		88
Total liabilities	$	8,132	$	1,436

Schedule of Weighted-Average Common Shares Outstanding

We report two earnings per share numbers, basic and diluted. These are computed by dividing net earnings by the weighted-average common shares outstanding (basic EPS) or weighted-average common shares outstanding assuming dilution (diluted EPS), as set forth below:

	THREE-MONTHS ENDED SEPTEMBER 30,				NINE-MONTHS ENDED SEPTEMBER 30,
In thousands	2013		2012		2013		2012
Weighted average shares outstanding		30,353		30,343		30,347		30,338
Dilutive effect of equity-based compensation plans		—		—		—		—
Weighted average shares outstanding, assuming dilution		30,353		30,343		30,347		30,338

XML

Long-Term Debt - Summary of Long-Term Debt Outstanding (Parenthetical) (Detail)	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Class B Term Loan due 2017 [Member]
Debt Instrument [Line Items]
Long-term debt, maturity year	2017	2017
Class C Term Loan due 2018 [Member]
Debt Instrument [Line Items]
Long-term debt, maturity year	2018	2018
Class A Term Loan due 2014 [Member]
Debt Instrument [Line Items]
Long-term debt, maturity year	2014	2014
Incremental Term Loan due 2018 [Member]
Debt Instrument [Line Items]
Long-term debt, maturity year	2018	2018
Ten Point Zero Percentage Senior Subordinated Notes Due Two Thousand Seventeen [Member]
Debt Instrument [Line Items]
Long-term debt, maturity year	2017	2017
Long-term debt, interest percentage	10.00%	10.00%
8.875% Senior PIK-election Notes due 2015 [Member]
Debt Instrument [Line Items]
Long-term debt, maturity year	2015	2015
Long-term debt, interest percentage	8.875%	8.875%

XML

Description of Business - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2013 Hospital Center Location Facilities Physician States
Schedule Of Description Of Business [Line Items]
Conversion rate units into stock/options	10.25
Number of states in which business operates	34
Number of Ambulatory Surgery Center Facilities	168
Number of surgical hospitals	5
Number of sleep centers	One sleep center with 11 locations
Number of ASCs deconsolidated	2
Number of surgical hospitals acquired	1
Number of de novo ASCs placed into operations	2
Number of ASCs agreed to manage	19
Number of sleep centers agreed to manage	1
Number of sleep center locations agreed to manage	11
Number of physician partners	2,000
Total facilities	174
Noncontrolling Interest [Member]
Schedule Of Description Of Business [Line Items]
Number of Ambulatory Surgery Center Facilities acquired	5
Controlling Interest [Member]
Schedule Of Description Of Business [Line Items]
Number of Ambulatory Surgery Center Facilities acquired	1
Options Held [Member]
Schedule Of Description Of Business [Line Items]
Conversion rate units into stock/options	10.25
Restricted Stock [Member]
Schedule Of Description Of Business [Line Items]
Conversion rate units into stock/options	10.25

XML

Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Classifications of Assets and Liabilities of Future Joint Venture (Detail) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013		Apr. 30, 2013	Dec. 31, 2012
Current assets
Accounts receivable, net	$ 81,235			$ 79,401
Total current assets	228,299			264,473
Property and equipment, net	183,687			179,922
Goodwill	701,971		679	706,495
Intangible assets	50,926			48,091
Total assets	1,363,003	[1]		1,409,176	[1]
Current liabilities
Total current liabilities	187,799			173,778
Other long-term liabilities	23,111			21,191
Total liabilities	1,111,490	[1]		1,070,590	[1]
Future JV [Member]
Current assets
Accounts receivable, net	3,767			1,867
Other current assets	9,613			4,635
Total current assets	13,380			6,502
Property and equipment, net	12,630			5,630
Goodwill	12,831			12,265
Intangible assets	5,205			5,792
Total assets	44,046			30,189
Current liabilities
Accounts payable and other current liabilities	4,357			1,348
Total current liabilities	4,357			1,348
Other long-term liabilities	3,775			88
Total liabilities	$ 8,132			$ 1,436

[1] Our consolidated assets as of September 30, 2013 and December 31, 2012 include total assets of a variable interest entity ("VIE") of $44.0 million and $30.2 million, respectively, which can only be used to settle the obligations of the VIE. Our consolidated total liabilities as of September 30, 2013 and December 31, 2012 include total liabilities of the VIE of $8.1 million and $1.4 million, respectively, for which the creditors of the VIE have no recourse to us. See further description in Note 3, Summary of Significant Accounting Policies.

XML

Long-Term Debt - Summary of Changes in Components of Accumulated Other Comprehensive Loss, Net of Related Income Tax Effects (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Debt Disclosure [Abstract]
Balance at Beginning of Period			$ (8,327)
Other comprehensive income before reclassifications			847
Amounts reclassified from accumulated other comprehensive loss		1,810	7,480	5,351
Balance at End of Period

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Schedule of Fair Values of Our Assets and Liabilities that are Measured on Recurring Basis

The fair values of our assets and liabilities that are measured on a recurring basis are as follows (in millions):

	September 30, 2013
	Fair Value Measurements Using						Total Assets/Liabilities at Fair Value		Valuation Technique1
	Level 1		Level 2		Level 3
Assets
Other long-term assets	$	—	$	—	$	1.7	$	1.7	I
Total assets	$	—	$	—	$	1.7	$	1.7
Liabilities
Other current liabilities	$	—	$	—	$	—	$	—	I
Other long-term liabilities		—		3.3	$	—		3.3	I
Total liabilities	$	—	$	3.3	$	—	$	3.3

	December 31, 2012
	Fair Value Measurements Using								Valuation
	Level 1		Level 2		Level 3		Total		Technique1
Liabilities
Other current liabilities	$	—	$	2.2	$	—	$	2.2	I
Other long-term liabilities		—		3.9	$	—		3.9	I
Total liabilities	$	—	$	6.1	$	—	$	6.1

¹  As discussed above, the authoritative guidance identifies three valuation techniques: market approach (M), cost approach (C), and income approach (I).

Schedule of Quantitative Information Associated with Fair Value Measurement of Our Recurring Level 3 Inputs

The following table provides quantitative information associated with the fair value measurement of our recurring Level 3 inputs (in millions):

Level 3 Contingent Consideration	Level 3 Assets as of September 30, 2013	Significant Unobservable Input		Range of Inputs	Weighted Average
Income Approach	$ 1.7	Probabilities of retention of management contracts	(a)	10% - 100%	80%

(a) The fair value of adjustment to the contingent consideration is based on a formula driven threshold contract value set at the time of the HI transaction. The threshold contract value is a function of revenue and probability of retention of each contract over 12 to 18 months from the transaction date. Significant increases or decreases in any of the probabilities of renewal would result in a significantly lower or higher fair value measurement, respectively.

Schedule of Roll-Forward of Recurring Fair Value Balance Used Level 3 Inputs

The following table provides a roll-forward of the recurring fair value balance that used Level 3 inputs (in millions):

	Contingent Consideration
Beginning balance as of December 31, 2012	$	—
Addition of contingent consideration asset		1.7
Ending balance as of September 30, 2013	$	1.7

Schedule of Investment in Nonconsolidated Affiliate Measured at Fair Value on Nonrecurring Basis

The investment in nonconsolidated affiliate measured at fair value on a nonrecurring basis is as follows (in millions of U.S. dollars):

			Fair Value Measurements Using
September 30, 2013	Net Carrying Value as of:		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses Year-ended:
Investment in nonconsolidated affiliate	$	1.3		—		—	$	1.3	$	1.2
June 30, 2013	Net Carrying Value as of:		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses Year-ended:
Investment in nonconsolidated affiliate	$	2.9		—		—	$	2.9	$	1.5

Schedule of Property and Equipment Measured at Fair Value on Nonrecurring Basis

Property and equipment measured at fair value on a nonrecurring basis are as follows (in millions of U.S. dollars):

			Fair Value Measurements Using
March 31, 2012	Net Carrying Value as of:		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses Year-ended:
Property and equipment	$	0.9		—		—	$	0.9	$	0.4

Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments

The fair values utilize inputs other than quoted prices in active markets, although the inputs are observable either directly or indirectly; accordingly, the fair values are in level 2 of the fair value hierarchy.

	As of September 30, 2013				As of December 31, 2012
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Interest rate swap agreements (includes short-term component)	$	3,263	$	3,263	$	6,105	$	6,105
Long-term debt:
Advances under $132.3 million Class B Revolving Credit Facility	$	—	$	—	$	—	$	—
Class A Term Loan due 2014		—		—		118,970		118,673
Class B Term Loan due 2017		214,980		214,980		216,634		215,280
Class C Term Loan due 2018		389,025		386,350		—		—
Incremental Term Loan due 2018		—		—		98,500		98,500
8.875%/9.625% Senior PIK-Election Notes due 2015		—		—		164,785		167,119
10% Senior Subordinated Notes due 2017		150,000		155,719		150,000		157,313
Notes payable to banks and others		38,880		38,880		24,338		24,338
Financial commitments	$	—	$	—	$	—	$	—

Investment in Nonconsolidated Affiliate [Member]

Schedule of Quantitative Information Associated with Fair Value Measurement of Our Recurring Level 3 Inputs

The following table includes information regarding the significant unobservable input used in the estimation of Level 3 fair value measurement.

Level 3 Investment in nonconsolidated affiliate	Level 3 Assets as of September 30, 2013	Significant Unobservable Inputs	Range of Inputs
Income Approach	$ 1.3	WACC	11.4%
		Revenue growth rates	2.9% - 5.7%

Level 3 Investment in nonconsolidated affiliate	Level 3 Assets as of June 30, 2013	Significant Unobservable Input			Range of Inputs
Market Approach	$2.9	Exit price	(a	)	$2.9

(a) The exit price was determined using the amount stated in a firm offer letter for the investment.

Property and Equipment [Member]

Schedule of Quantitative Information Associated with Fair Value Measurement of Our Recurring Level 3 Inputs

The following table includes information regarding significant unobservable inputs used in the estimation of Level 3 fair value measurement.

Level 3 Property and equipment	Level 3 Assets as of March 31, 2012		Significant Unobservable Input			Range of Inputs		Weighted Average
Market Approach	$	0.9	Price per square foot	(a	)	$	109	$	109

(a) Price per square foot is multiplied times the total square footage of a facility to determine the approximate market value.

XML

Equity-Based Compensation - Additional Information (Detail) (USD $) In Millions, except Share data, unless otherwise specified	0 Months Ended	3 Months Ended	9 Months Ended
	Sep. 16, 2013	Sep. 30, 2013	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion rate units into stock/options			10.25
Number of options, vested			1,958,827
Cash bonus per unit	0.24
Reduction in exercise price of option	$ 0.24
Additional compensation expense		$ 4.6	$ 4.6
Additional stock-based compensation expense			1.6
Unrecognized compensation cost		7.9	7.9
Share-based compensation, nonvested awards, weighted average period			2 years 8 months 12 days
Options Held [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion rate units into stock/options			10.25
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion rate units into stock/options			10.25
Performance Based Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options, vested	806,303
Additional stock-based compensation expense		$ 0.8
Vested Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash bonus per unit	2.46
Unvested Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reduction in exercise price of option	$ 2.46

XML

Subsequent Events - Additional Information (Detail) (USD $)	9 Months Ended		0 Months Ended							1 Months Ended
	Sep. 30, 2013	Sep. 30, 2013 Initial Public Offering [Member]	Nov. 04, 2013 Subsequent Event [Member]	Nov. 04, 2013 Subsequent Event [Member] Senior Subordinated Notes [Member]	Nov. 04, 2013 Subsequent Event [Member] Minimum [Member] Senior Subordinated Notes [Member]	Nov. 04, 2013 Subsequent Event [Member] Maximum [Member] Senior Subordinated Notes [Member]	Nov. 04, 2013 Subsequent Event [Member] Initial Public Offering [Member]	Nov. 04, 2013 Subsequent Event [Member] Shareholders' Equity [Member]	Nov. 04, 2013 Subsequent Event [Member] Initial Public Offering Underwriters [Member]	Oct. 01, 2013 Subsequent Event [Member] ASC [Member]
Schedule of Equity Method Investments [Line Items]
Acquired controlling interest										$ 900,000
Acquired non-controlling interest										1,300,000
Amount of initial public offering							9,777,778
Total stock sold in initial offering			11,244,444
Sale of shares by selling shareholders								1,920,635
Purchase of shares by underwriters									1,466,666
Common stock value per share							$ 24.00
Extinguishment of Senior Subordinated Notes				150,000,000
Loss on extinguishment	(3,800,000)				6,500,000	7,000,000
Fee payable under our management services agreement		$ 8,000,000

XML

Fair Value of Financial Instruments - Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments (Parenthetical) (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2012
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Class B Revolving Credit Facility amount	$ 132.3
Class A Term Loan due 2014 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long term debt, maturity year	2014	2014
Class B Term Loan due 2017 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long term debt, maturity year	2017	2017
Class C Term Loan due 2018 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long term debt, maturity year	2018	2018
Incremental Term Loan due 2018 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long term debt, maturity year	2018
8.875%/9.625% Senior PIK-Election Notes due 2015 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long term debt, maturity year	2015
10% Senior Subordinated Notes due 2017 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long term debt, maturity year	2017
Long term debt, interest percentage	10.00%
Minimum [Member] | 8.875%/9.625% Senior PIK-Election Notes due 2015 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long term debt, interest percentage	8.875%
Maximum [Member] | 8.875%/9.625% Senior PIK-Election Notes due 2015 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long term debt, interest percentage	9.625%

XML

Results of Operations of Nonconsolidated Affiliates - Summary of Combined Results of Operations of Our Equity Method Affiliates (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net operating revenues:
Net patient revenues	$ 177,686	$ 173,636	$ 548,685	$ 526,512
Other revenues	4,208	2,747	10,580	8,797
Total net operating revenues	195,083	180,778	585,485	548,938
Operating expenses:
Salaries and benefits	74,788	59,153	202,189	180,112
Supplies	42,565	41,030	128,242	124,211
Other operating expenses	31,080	28,374	89,293	89,576
Depreciation and amortization	10,993	10,076	31,928	30,414
Total operating expenses	169,953	149,377	482,733	454,804
Operating income	29,235	36,291	118,863	110,810
Loss on sale of investments	(75)		(1,060)	2,001
Income from continuing operations before income tax expense	14,683	22,088	65,353	68,388
Net income	8,700	19,137	50,953	55,611
Equity Method Affiliates [Member]
Net operating revenues:
Net patient revenues	152,617	113,730	415,970	345,118
Other revenues	1,326	433	3,763	2,370
Total net operating revenues	153,943	114,163	419,733	347,488
Operating expenses:
Salaries and benefits	34,048	26,770	93,468	81,163
Supplies	26,136	19,064	70,446	57,404
Other operating expenses	30,569	25,202	85,247	73,594
Depreciation and amortization	4,698	3,534	12,544	10,380
Total operating expenses	95,451	74,570	261,705	222,541
Operating income	58,492	39,593	158,028	124,947
Interest expense, net of interest income	516	387	1,185	1,159
Loss on sale of investments			(21)
Income from continuing operations before income tax expense	57,976	39,206	156,822	123,788
Net income	$ 57,964	$ 39,188	$ 156,777	$ 123,745

XML

Discontinued Operations - Schedule of Operating Results, Assets and Liabilities Related to Discontinued Operations (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Discontinued Operations And Disposal Groups [Abstract]
Net operating revenues	$ 589	$ 3,094	$ 2,399	$ 11,810
Gain (loss) on sale of investments or closures	24	1,351	(2,226)	(1,858)
Costs and expenses	(716)	(3,494)	(3,772)	(13,484)
(Loss) income from discontinued operations	(103)	951	(3,599)	(3,532)
Income tax (expense) benefit	(152)	90	(638)	(581)
Net (loss) income from discontinued operations	(255)	1,041	(4,237)	(4,113)
Current assets
Accounts receivable, net	204		204		1,162
Other current assets	108		108		237
Total current assets	312		312		1,399
Property and equipment, net	1,897		1,897		2,263
Other long term assets	231		231		234
Total assets	2,440		2,440		3,896
Current liabilities
Accounts payable and other current liabilities	298		298		456
Total current liabilities	298		298		456
Other long-term liabilities	403		403		397
Total liabilities	$ 701		$ 701		$ 853

XML

Transactions, Deconsolidations and Closures (Tables)

9 Months Ended

Sep. 30, 2013

Summary of Amounts Recognized as of Acquisition Date for Each Major Class of Assets and Liabilities

The amounts recognized as of the acquisition date for each major class of assets and liabilities assumed are as follows:

Assets
Property and equipment	$	2,971
Goodwill		679
Intangible assets		350
Total assets	$	4,000
Liabilities
Total liabilities	$	—

Health Inventures, LLC [Member]

Summary of Amounts Recognized as of Acquisition Date for Each Major Class of Assets and Liabilities

The HI amounts recognized as of the acquisition date for each major class of assets and liabilities assumed are as follows:

Assets
Current assets
Cash and cash equivalents	$	1,179
Accounts receivable		2,130
Other current assets		400
Total current assets		3,709
Property and equipment		584
Goodwill		2,269
Intangible assets		7,605
Investment in and advances to nonconsolidated affiliates		4,360
Total assets	$	18,527
Liabilities
Current liabilities
Accounts payable and other current liabilities	$	1,742
Total current liabilities		1,742
Total liabilities	$	1,742

XML

Condensed Consolidated Statements of Changes in Equity (USD $) In Thousands	Total	Members Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total Surgical Care Affiliates Equity [Member]	Noncontrolling Interests- Non-redeemable [Member]
Balance at Dec. 31, 2011	$ 302,586	$ 313,781	$ (9,313)	$ (137,299)	$ 167,169	$ 135,417
Net (loss) income	37,330			(13,249)	(13,249)	50,579
Other comprehensive income	235		235		235
Stock compensation	1,260	1,260			1,260
Net change in equity related to purchase/(sale) of ownership interests	7,376	(3,127)			(3,127)	10,503
Change in distribution accrual	(300)					(300)
Distributions to noncontrolling interests	(52,461)					(52,461)
Balance at Sep. 30, 2012	296,026	311,914	(9,078)	(150,548)	152,288	143,738
Balance at Dec. 31, 2012	316,877	310,019	(8,327)	(157,309)	144,383	172,494
Member Distributions	(74,615)	(74,615)			(74,615)
Net (loss) income	30,674			(23,907)	(23,907)	54,581
Other comprehensive income	8,327		8,327		8,327
Stock compensation	2,093	2,093			2,093
Net change in equity related to purchase/(sale) of ownership interests	2,442	319			319	2,123
Contributions from noncontrolling interests	1,413					1,413
Change in distribution accrual	255					255
Distributions to noncontrolling interests	(58,676)					(58,676)
Balance at Sep. 30, 2013	$ 228,790	$ 237,816		$ (181,216)	$ 56,660	$ 172,190

XML

Condensed Consolidated Statements of Cash Flows (Parenthetical) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Statement Of Cash Flows [Abstract]
Business acquisition, cash acquired	$ 1,179

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The consolidated financial statements include the accounts of the Company, its subsidiaries and VIEs for which we are the primary beneficiary. All significant intercompany transactions and accounts have been eliminated.

We evaluate partially owned subsidiaries and joint ventures held in partnership form using authoritative guidance, which includes a framework for evaluating whether a general partner(s) or managing member(s) controls an affiliate and therefore should consolidate it. The framework includes the presumption that general partner or managing member control would be overcome only when the limited partners or members have certain rights. Such rights include the right to dissolve or liquidate the LP, limited liability partnership (“LLP”) or LLC or otherwise remove the general partner or managing member “without cause,” or the right to effectively participate in significant decisions made in the ordinary course of business of the LP, LLP or LLC. To the extent that any noncontrolling investor has rights that inhibit our ability to control the affiliate, including substantive veto rights, we do not consolidate the affiliate.

We use the equity method to account for our investments in affiliates with respect to which we do not have control rights but have the ability to exercise significant influence over operating and financial policies. Assets, liabilities, revenues and expenses are reported in the respective detailed line items on the consolidated financial statements for our consolidated affiliates. For our equity method affiliates, assets and liabilities are reported on a net basis in Investment in and advances to nonconsolidated affiliates on the consolidated balance sheets, and revenues and expenses are reported on a net basis in Equity in net income of nonconsolidated affiliates on the condensed consolidated statements of operations. This difference in accounting treatment of equity method affiliates impacts certain financial ratios of the Company.

Variable Interest Entities

In order to determine if we are the primary beneficiary of a VIE for financial reporting purposes, we consider whether we have the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and whether we have the obligation to absorb losses or the right to receive returns that would be significant to the VIE. We consolidate a VIE when we are the primary beneficiary.

In 2012, the Company entered into a transaction whereby we transferred our interest in two consolidated facilities and cash to an entity (the “future JV”) wholly owned by a health system in exchange for a promissory note. Concurrently, the health system transferred its interest in a facility it controlled to the future JV. The promissory note, which eliminates upon consolidation, has a fixed interest rate plus a variable component dependent on the earnings of the future JV. The promissory note contains a conversion feature that allows us to convert the promissory note to a 49% equity interest in the future JV at our option upon the occurrence of the renegotiation of certain contractual arrangements. We also entered into management services agreements with the facilities controlled by the future JV. As a result of the financial interest in the earnings of the future JV held by us via the promissory note and the powers granted us in the promissory note and the management services agreements, we have determined that the future JV is a VIE for which we are the primary beneficiary. We consolidated the future JV as of October 1, 2012.

The carrying amounts and classifications of the assets and liabilities of the future JV, which are included in our September 30, 2013 and December 31, 2012 consolidated balance sheets, were as follows:

	SEPTEMBER 30, 2013		DECEMBER 31, 2012
Assets
Current assets
Accounts receivable, net	$	3,767	$	1,867
Other current assets		9,613		4,635
Total current assets		13,380		6,502
Property and equipment, net		12,630		5,630
Goodwill		12,831		12,265
Intangible assets		5,205		5,792
Total assets	$	44,046	$	30,189
Liabilities
Current liabilities
Accounts payable and other current liabilities	$	4,357	$	1,348
Total current liabilities		4,357		1,348
Other long-term liabilities		3,775		88
Total liabilities	$	8,132	$	1,436

The assets of the consolidated VIE can only be used to settle the obligations of the VIE. The creditors of the VIE have no recourse to us.

Investment in and Advances to Nonconsolidated Affiliates

Investments in entities we do not control, but in which we have the ability to exercise significant influence over the operating and financial policies of the investee, are accounted for under the equity method. Equity method investments are recorded at original cost and adjusted periodically to recognize our proportionate share of the investees’ net income or losses after the date of investment, additional contributions made and distributions received, amortization of definite lived intangible assets attributable to equity method investments and impairment losses resulting from adjustments to the carrying value of the investment. We record equity method losses in excess of the carrying amount of an investment when we guarantee obligations or we are otherwise committed to provide further financial support to the affiliate.

Reclassifications and Revisions

Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. Such reclassifications primarily relate to facilities we closed or sold, which qualify for reporting as discontinued operations.

During the third quarter of 2013, we recorded an adjustment increasing Interest expense by approximately $2.2 million related to the correction of an under-accrual of Interest expense during the second quarter of 2013. We do not believe this adjustment is material to either our current period financial statements or our previously issued financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Earnings Per Share (EPS)

We report two earnings per share numbers, basic and diluted. These are computed by dividing net earnings by the weighted-average common shares outstanding (basic EPS) or weighted-average common shares outstanding assuming dilution (diluted EPS), as set forth below:

	THREE-MONTHS ENDED SEPTEMBER 30,				NINE-MONTHS ENDED SEPTEMBER 30,
In thousands	2013		2012		2013		2012
Weighted average shares outstanding		30,353		30,343		30,347		30,338
Dilutive effect of equity-based compensation plans		—		—		—		—
Weighted average shares outstanding, assuming dilution		30,353		30,343		30,347		30,338

The shares used reflect the conversion to a Delaware corporation discussed in Note 1 for all periods. All dilutive share equivalents are reflected in our earnings per share calculations. Antidilutive share equivalents are not included in our EPS calculations. In periods of loss, shares that otherwise would have been included in our diluted weighted-average shares outstanding computation are excluded. The excluded shares for the three-months ended September 30 are as follows: 2013 — 989,000 and 2012 — 354,000. The excluded shares for the nine-months ended September 30 are as follows: 2013 — 686,000 and 2012 — 339,000.

Reportable Segments

We have four operating segments, which combine into one reportable segment. Our four operating segments are generally organized geographically. For reporting purposes, we have combined our operating segments into one reportable segment as the nature of the services are similar and the businesses exhibit similar economic characteristics, processes, types and classes of customers, methods of service delivery and distribution and regulatory environments.

Distribution

On September 16, 2013, we declared a cash distribution of approximately $0.24 per outstanding membership unit, resulting in a total distribution to our membership unit holders of $74.9 million. The distribution was payable promptly after the date it was declared. In addition, on September 16, 2013, the board of directors of SCA resolved to pay a cash bonus to eligible holders of vested options and restricted equity units of approximately $0.24 per vested option or restricted equity unit, as applicable, resulting in a total bonus payment of $4.6 million, and to adjust downward the exercise price of any such holder’s unvested options by approximately $0.24 per unvested option. The cash bonus payment was recorded as compensation expense in the third quarter of 2013. In addition, we will record stock compensation expense over the remaining vesting periods related to the adjustment to unvested options.

Recent Revisions to Authoritative Guidance

In February 2013, the Financial Accounting Standards Board issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. This update requires companies to include reclassification adjustments for items that are reclassified from other comprehensive income to net income in a single note or on the face of the financial statements. The amendment was effective for annual and interim reporting periods beginning after December 15, 2012. The adoption of this standard did not have a material impact on the consolidated financial statements of the Company.

We do not believe any other recently issued, but not yet effective, revisions to authoritative guidance will have a material effect on our condensed consolidated financial position, results of operations or cash flows.

XML

Description of Business

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Description of Business

NOTE 1 — DESCRIPTION OF BUSINESS

Nature of Operations and Ownership of the Company

Surgical Care Affiliates, Inc., a Delaware corporation, was converted from a Delaware limited liability company, previously named ASC Acquisition LLC, to a Delaware corporation on October 30, 2013. Pursuant to the conversion, every 10.25 outstanding membership units of ASC Acquisition LLC were converted into one share of common stock of Surgical Care Affiliates, Inc., and options to purchase membership units of ASC Acquisition LLC were converted into options to purchase shares of common stock of Surgical Care Affiliates, Inc. at a ratio of 10.25 membership units of ASC Acquisition LLC underlying such options to each one share of common stock of Surgical Care Affiliates, Inc. underlying such converted options. In connection with the conversion, the exercise prices of such converted options were adjusted accordingly. In addition, every 10.25 outstanding restricted equity units of ASC Acquisition LLC were converted into one restricted share of Surgical Care Affiliates, Inc.

We were formed primarily to own and operate a network of multi-specialty ambulatory surgery centers (“ASCs”) and surgical hospitals in the United States of America. For all periods covered by our financial statements, we were a Delaware limited liability company named ASC Acquisition LLC. As of September 30, 2013, the Company operated in 34 states and had an interest in and/or operated 168 ASCs, five surgical hospitals and one sleep center with 11 locations, with a concentration of facilities in California, Indiana and Texas. Our ASCs and surgical hospitals primarily provide the facilities, equipment and medical support staff necessary for physicians to perform non-emergency surgical and other procedures in various specialties, including orthopedics, ophthalmology, gastroenterology, pain management, otolaryngology (ear, nose and throat, or “ENT”), urology and gynecology, as well as other general surgery procedures. At our ASCs, physicians perform same-day surgical procedures. At our surgical hospitals, physicians perform a broader range of surgical procedures, and patients may stay in the hospital for several days.

During the nine-months ended September 30, 2013, our portfolio of facilities changed as follows:

• we acquired a controlling interest in one ASC , which we consolidate;

• we deconsolidated two ASCs (i.e., we entered into a transaction that required a change in accounting treatment of the facility from consolidated to equity method investment);

• we acquired a noncontrolling interest in five ASCs and one surgical hospital that we hold as equity method investments;

• we placed two de novo ASCs into operations, one of which we consolidate and one we hold as an equity investment;

• we closed a consolidated ASC;

• we terminated a management agreement with a managed-only ASC, in which we held no equity interests; and

• we entered into agreements to manage nineteen ASCs and one sleep center with 11 locations.

Business Structure

We operate our facilities through strategic relationships with approximately 2,000 physician partners and often with healthcare systems that have strong local market positions and we believe have strong reputations for clinical excellence. The facilities in which we hold an ownership interest are owned by general partnerships, limited partnerships (“LP”), limited liability partnerships or limited liability companies (“LLC”) in which the Company serves as the general partner, limited partner, managing member or member. We account for our 174 facilities as follows:

	AS OF SEPTEMBER 30, 2013
Consolidated facilities		86
Equity method facilities		61
Managed only facilities		27
Total facilities		174

Basis of Presentation

The Company maintains its books and records on the accrual basis of accounting, and the accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), the instructions for Form 10-Q, Article 10 of Regulation S-X as promulgated by the Securities and Exchange Commission (the “SEC”) and the SEC’s regulations for interim financial information. Such financial statements include the assets, liabilities, revenues and expenses of all wholly-owned subsidiaries, subsidiaries over which we exercise control and, when applicable, affiliates in which we have a controlling financial interest. These interim financial statements do not include all of the disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited financial statements of the Company reflect all adjustments (consisting only of normal, recurring items) necessary for a fair statement of the results for the interim periods presented. Operating results for the three- and nine-month periods ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year-ended December 31, 2013. The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company’s audited December 31, 2012 consolidated financial statements included in our final Prospectus filed with the SEC on October 30, 2013 pursuant to Rule 424(b).

XML

Summary of Significant Accounting Policies - Schedule of Weighted-Average Common Shares Outstanding (Detail) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Accounting Policies [Abstract]
Weighted average shares outstanding	30,353	30,343	30,347	30,338
Dilutive effect of equity-based compensation plans
Weighted average shares outstanding, assuming dilution	30,353	30,343	30,347	30,338

XML

Results of Operations of Nonconsolidated Affiliates (Tables)

9 Months Ended

Sep. 30, 2013

Equity Method Investments And Joint Ventures [Abstract]

Summary of Combined Results of Operations of Our Equity Method Affiliates

The following summarizes the combined results of operations of our equity method affiliates:

	THREE-MONTHS ENDED SEPTEMBER 30,				NINE-MONTHS ENDED SEPTEMBER 30,
	2013		2012		2013		2012
Net operating revenues:
Net patient revenues	$	152,617	$	113,730	$	415,970	$	345,118
Other revenues		1,326		433		3,763		2,370
Total net operating revenues		153,943		114,163		419,733		347,488
Operating expenses:
Salaries and benefits		34,048		26,770		93,468		81,163
Supplies		26,136		19,064		70,446		57,404
Other operating expenses		30,569		25,202		85,247		73,594
Depreciation and amortization		4,698		3,534		12,544		10,380
Total operating expenses		95,451		74,570		261,705		222,541
Operating income		58,492		39,593		158,028		124,947
Interest expense, net of interest income		516		387		1,185		1,159
Loss on sale of investments		—		—		21		—
Income from continuing operations before income tax expense	$	57,976	$	39,206	$	156,822	$	123,788
Net income	$	57,964	$	39,188	$	156,777	$	123,745

XML

Equity-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2013

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Share-Based Activity

Information pertaining to share-based activity during the three- and nine- months ended September 30, 2013 and 2012 was as follows (in thousands):

	Three-months Ended				Nine-months Ended
	September 30,				September 30,
	2013		2012		2013		2012
Stock-based compensation expense	$	1,664	$	459	$	2,093	$	1,260

Summary of Status in Non-Vested Restricted Shares

A summary of the status of non-vested restricted shares at September 30, 2013 and changes during the nine-months ended September 30, 2013 is as follows:

	Number of Shares			Weighted Average Grant Price
Non-vested shares at December 31, 2012		19,712		$	10.63
Shares granted		51,417			22.93
Shares vested		(16,685	)		10.63
Non-vested shares at September 30, 2013		54,444		$	22.93

Summary of Stock Option Activity

A summary of stock option activity for the nine-months ended September 30, 2013 is summarized as follows:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)
Outstanding at December 31, 2012		2,387,646	$	11.00		5.72
Outstanding at September 30, 2013		2,996,101	$	11.27		5.89
Vested at September 30, 2013		1,958,827	$	11.30		5.72

XML

Commitments and Contingent Liabilities - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2013
Operating Leased Assets [Line Items]
Non-cancelable operating leases expiration dates	Various dates through 2031
Capital leases expiration dates	Various dates through 2023
Minimum [Member]
Operating Leased Assets [Line Items]
Operating leases terms	5 years
Maximum [Member]
Operating Leased Assets [Line Items]
Operating leases terms	22 years

XML

Transactions, Deconsolidations and Closures - Summary of Amounts Recognized as of Acquisition Date for Each Major Class of Assets and Liabilities (Detail) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Apr. 30, 2013	Dec. 31, 2012
Assets
Property and equipment		$ 2,971
Goodwill	701,971	679	706,495
Intangible assets		350
Total assets		4,000
Liabilities
Total liabilities

XML

Related Party Transactions - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
TPG Capital Limited Partnership [Member]
Related Party Transaction [Line Items]
Management fees paid	$ 0.5	$ 0.5	$ 1.5	$ 1.5
Credit Agreement, amendment date			May 08, 2013
Amendment arrangement fee			0.5
Underwriting discount			0.7
Bradley Arant Boult Cummings Limited Liability Partnership [Member]
Related Party Transaction [Line Items]
Legal services fees	$ 0.4	$ 0.3	$ 1.0	$ 0.6

XML

Fair Value of Financial Instruments - Schedule of Quantitative Information Associated with Fair Value Measurement of Our Recurring Level 3 Inputs (Detail) (Fair Value, Measurements, Recurring [Member], Income Approach [Member], Significant Unobservable Inputs (Level 3) [Member], USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Level 3 Assets Contingent Consideration	$ 1.7
Significant Unobservable Input	Probabilities of retention of management contracts
Weighted Average	80.00%
Minimum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Range of Inputs	10.00%
Maximum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Range of Inputs	100.00%

XML

Noncontrolling Interests - Breakout of Net Income (Loss) Between Continuing and Discontinued Operations (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Noncontrolling Interest [Abstract]
Net loss from continuing operations, net of tax, attributable to Surgical Care Affiliates	$ (12,453)	$ (4,033)	$ (19,670)	$ (9,136)
Net (loss) income from discontinued operations, net of tax, attributable to Surgical Care Affiliates	(255)	1,041	(4,237)	(4,113)
Net loss attributable to Surgical Care Affiliates	$ (12,708)	$ (2,992)	$ (23,907)	$ (13,249)

XML

Long-Term Debt - Summary of Long-Term Debt Outstanding (Detail) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Bonds payable
Capital lease obligations	$ 18,929	$ 17,295
Long-term debt and capital lease obligations	810,913	789,736
Less: Current portion	(21,711)	(15,220)
Long-term debt, net of current portion	789,202	774,516
Class B Term Loan due 2017 [Member]
Bonds payable
Long-term debt	214,980	216,634
Class C Term Loan due 2018 [Member]
Bonds payable
Long-term debt	389,025
Long-term debt	388,100
Discount on loans	(901)
Class A Term Loan due 2014 [Member]
Bonds payable
Long-term debt		118,970
Incremental Term Loan due 2018 [Member]
Bonds payable
Long-term debt		98,500
Discount on loans		(786)
Ten Point Zero Percentage Senior Subordinated Notes Due Two Thousand Seventeen [Member]
Bonds payable
Long-term debt	150,000	150,000
8.875% Senior PIK-election Notes due 2015 [Member]
Bonds payable
Long-term debt		164,785
Notes Payable to Banks and Others [Member]
Bonds payable
Long-term debt	$ 38,880	$ 24,338

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 8,336	$ 5,947
Consolidated assets, include variable interest entity	44,000	30,200
Consolidated liabilities, include variable interest entity	$ 8,100	$ 1,400

XML

Long-Term Debt

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Long-Term Debt

NOTE 6 — LONG-TERM DEBT

Our long-term debt outstanding consists of the following:

	As of
	September 30, 2013			December 31, 2012
Bonds payable
Class B Term Loan due 2017		214,980			216,634
Class C Term Loan due 2018		389,025			—
Discount of Class C Term Loan		(901	)		—
Class A Term Loan due 2014		—			118,970
Incremental Term Loan due 2018		—			98,500
Discount of Incremental Term Loan		—			(786	)
10.0% Senior Subordinated Notes due 2017		150,000			150,000
8.875% Senior PIK-election Notes due 2015		—			164,785
Notes payable to banks and others		38,880			24,338
Capital lease obligations		18,929			17,295
		810,913			789,736
Less: Current portion		(21,711	)		(15,220	)
Long-term debt, net of current portion	$	789,202		$	774,516

Senior Subordinated Notes and Senior PIK-election Notes

At September 30, 2013, we had $150.0 million of debt outstanding under our Senior Subordinated Notes due July 15, 2017 (“Senior Subordinated Notes”) at a fixed interest rate of 10.0%.

In connection with the amendment to the Credit Facility in the second quarter of 2013, on June 14, 2013 we extinguished the Senior PIK-election Notes at par, including a payment of accrued interest through July 15, 2015.

The Senior Subordinated Notes are unsecured senior subordinated obligations of SCA and Surgical Holdings, Inc., as co-issuer (the “Co-Issuer”); however, the Senior Subordinated Notes are guaranteed by certain of SCA’s current and future direct 100% owned domestic subsidiaries. Additionally, the indenture (the “Indenture”) pursuant to which the Senior Subordinated Notes were issued contains various restrictive covenants, including covenants that generally limit SCA’s ability and the ability of its restricted subsidiaries to borrow money or guarantee other indebtedness, incur liens, make certain investments, sell assets or pay dividends. The Company believes SCA and the Co-Issuer were in compliance with these covenants as of September 30, 2013.

Senior Secured Credit Facility (“Credit Facility”)

With respect to the Credit Facility, as of September 30, 2013, we had $604.0 million outstanding under the senior secured term loan facility consisting of the following:

• $215.0 million under the Class B Term Loan (as defined herein) due December 30, 2017. The interest rate on the Class B Term Loan was 4.25% at September 30, 2013.

• $389.0 million under the Class C Term Loan (as defined herein) due June 30, 2018. The interest rate on the Class C Term Loan was 4.25% at September 30, 2013.

We must repay the Class B Term Loan and the Class C Term Loan in quarterly installments equal to 0.25% of the original principal amount, with the remaining amount payable in full on the maturity date noted above.

Borrowings under each portion of the Credit Facility bear interest at a base rate or at the London interbank market for the interest period relevant to such borrowings (“LIBOR”), as elected by SCA, plus an applicable margin. The base rate is determined by reference to the higher of (i) the prime rate of JPMorgan Chase Bank, N.A. and (ii) the federal funds effective rate plus 0.50%. The LIBOR rate is determined by reference to the interest rate for dollar deposits in the London interbank market for the interest period relevant to such borrowings. The below table outlines the applicable margin for each portion of the Credit Facility.

Facility	Applicable Margin (per annum)
	Base Rate Borrowings	LIBOR Borrowings
Class B Revolving Credit Facility	2.50%	3.50%
Class B Term Loan	3.00%	4.00%
Class C Term Loan	2.00% or 2.25% (with a base rate floor of 2.00%) depending upon the total leverage ratio	3.00% or 3.25% (with a LIBOR floor of 1.00%) depending upon the total leverage ratio

There was no outstanding balance under the senior secured revolving credit facility (the “Class B Revolving Credit Facility”) as of September 30, 2013 or December 31, 2012. As of September 30, 2013 the Revolver has a capacity of $132.3 million under the Class B revolver with a maturity date of June 30, 2016.

On June 29, 2013, our Class A Revolving Credit Facility was terminated after we decided not to renew such revolving credit facility given that we believe we have sufficient available borrowing capacity for our operations under our Class B Revolving Credit Facility.

Any utilization of the Class B Revolving Credit Facility (other than issuances of up to an aggregate of $5.0 million of letters of credit) will be subject to compliance with a total leverage ratio test. At September 30, 2013, we had approximately $1.7 million in such letters of credit outstanding.

2013 Amendment to the Credit Facility

In the second quarter of 2013, we amended our credit agreement (the “Amended Credit Agreement”). The Amended Credit Agreement provides for a Class C Term Loan Facility (“Class C Term Loan”) of $389.0 million ($388.1 million, net of discount) as of September 30, 2013. The Class C Term Loan will mature on June 30, 2018. We utilized the proceeds of the Class C Term Loan plus $8.7 million in cash to extinguish the PIK-election Notes, the Class A Term Loan and the Incremental Term Loan. The applicable margin for borrowings under the Class C Term Loan is (i) 2.25% with respect to base rate borrowings (with a base rate floor of 2.00%) and (ii) 3.25% with respect to LIBOR borrowings (with a LIBOR floor of 1.00%). The interest rate on the Class C Term Loan was 4.25% at September 30, 2013. Until maturity, quarterly amortization payments will be made in an amount equal to 0.25% of the original principal amount of the Class C Term Loan.

In connection with the settlement of existing debt due to Class C Term Loan, we incurred a loss on extinguishment of debt of $3.8 million.

The Credit Facility is guaranteed by the Company and certain of SCA’s direct 100% owned domestic subsidiaries (the “guarantors”), subject to certain exceptions, and borrowings under the Credit Facility are secured by a first priority security interest in all equity interests of SCA and of each 100% owned domestic subsidiary directly held by SCA or a guarantor. Additionally, the Credit Facility contains various restrictive covenants that, subject to certain exceptions, prohibit us from prepaying certain subordinated indebtedness, including the Senior Subordinated Notes described above. In addition, the Credit Facility generally restricts SCA and SCA’s restricted subsidiaries’ ability to, among other things, incur indebtedness or liens, make investments or declare or pay dividends. The Company believes it and SCA were in compliance with these covenants as of September 30, 2013.

Interest Rate Swaps

The Company utilizes an interest rate risk management strategy that incorporates the use of derivative financial instruments to limit its exposure to interest rate risk. The swaps are “receive floating/pay fixed” instruments that define a fixed rate of interest on the economically hedged debt that the Company will pay, meaning we receive floating rate payments, which fluctuate based on LIBOR, from the counterparty and pay at a fixed rate to the counterparty, the result of which is to convert the interest rate of a portion of our floating rate debt into fixed rate debt, or to limit the variability of interest related payments caused by changes in LIBOR. At December 31, 2012, interest rate swaps on $240.0 million of the $335.6 million Class A and Class B Term Loans remained outstanding. As a result of the amendment to the Credit Facility, we de-designated the cash flow hedging instruments. The de-designation resulted in the reclassification of all amounts related to the cash flow hedges in Accumulated other comprehensive loss to be reclassified to Interest expense.

The following table presents changes in the components of Accumulated other comprehensive loss, net of related income tax effects:

	NINE-MONTHS ENDED SEPTEMBER  30, 2013
Balance at Beginning of Period	$	(8,327	)
Other comprehensive income before reclassifications		847
Amounts reclassified from accumulated other comprehensive loss		7,480
Balance at End of Period	$	—

All derivative instruments are recognized on the balance sheet on a gross basis at fair value. The fair value of the interest rate swaps is recorded in the Company’s condensed consolidated balance sheets, either in Other current liabilities and Other long-term liabilities or Prepaids and other current assets and Other long-term assets, depending on the changes in the fair value of the swaps and the period remaining until the expiration of the swap, with an offsetting adjustment reported as Interest expense on the Company’s condensed consolidated statements of operation. At December 31, 2012, gross liabilities in the amount of $2.2 million were included in Other current liabilities, and $3.3 million and $3.9 million were included in Other long-term liabilities at September 30, 2013 and December 31, 2012, respectively, in the condensed consolidated balance sheets based on the fair value of the derivative instruments. No gross liabilities were included in Other current liabilities as of September 30, 2013 in the condensed consolidated balance sheets. Although all our derivative instruments are subject to master netting arrangements, no amounts have been netted against the gross liabilities previously detailed and no collateral has been posted with counterparties. During the nine-months ended September 30, 2013, the liability related to the swaps decreased by $2.8 million. The decrease was due to swap settlements and the change in fair value resulting in a $2.2 million decrease in Other current liabilities and a $0.6 million decrease in Other long-term liabilities. During the three month period ended September 30, 2013, the Company recorded losses of approximately $0.5 million within Interest expense due to changes in fair value of derivative instruments. During the nine month period ended September 30, 2013, the Company recorded losses of approximately $8.1 million within Interest expense due to the de-designation of interest rate swaps and subsequent changes in fair value of derivative instruments.

The accounting for changes in fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge related to foreign currency exposure. The Company previously designated its interest rate swaps as a cash flow hedge; however, as noted above, the interest rate swaps were de-designated as hedges in the second quarter of 2013.

Credit risk occurs when a counterparty to a derivative instrument fails to perform according to the terms of the agreement. Derivative instruments expose the Company to credit risk and could result in material changes from period to period. The Company minimizes its credit risk by entering into transactions with highly rated counterparties. In addition, at least quarterly, the Company evaluates its exposure to counterparties who have experienced or may likely experience significant threats to their ability to perform according to the terms of the derivative agreements to which we are a party. We have completed this review of the financial strength of the counterparty to our interest rate swaps using publicly available information, as well as qualitative inputs, as of September 30, 2013. Based on this review, we do not believe there is a significant counterparty credit risk associated with these derivative instruments. However, no assurances can be provided regarding our potential exposure to counterparty credit risk in the future.

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 8,700	$ 19,137	$ 50,953	$ 55,611
Other comprehensive (loss) income:
Unrealized gain (loss) on interest rate swap		(2,328)	847	(5,116)
Amounts reclassified from accumulated other comprehensive loss		1,810	7,480	5,351
Total other comprehensive income (loss)		(518)	8,327	235
Comprehensive income	8,700	18,619	59,280	55,846
Comprehensive income attributable to noncontrolling interests	(21,408)	(22,129)	(74,860)	(68,860)
Comprehensive loss attributable to Surgical Care Affiliates	$ (12,708)	$ (3,510)	$ (15,580)	$ (13,014)

XML

Fair Value of Financial Instruments - Schedule of Investment in Nonconsolidated Affiliate Measured at Fair Value on Nonrecurring Basis (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended	9 Months Ended
	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Losses on investment in nonconsolidated affiliate	$ 1.2	$ 1.5	$ 1.2
Fair Value, Measurements, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliate, Net Carrying Value	1.3	2.9	1.3
Total Losses on investment in nonconsolidated affiliate		1.5	1.2
Fair Value, Measurements, Nonrecurring [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliate, Net Carrying Value
Fair Value, Measurements, Nonrecurring [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliate, Net Carrying Value
Fair Value, Measurements, Nonrecurring [Member] | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliate, Net Carrying Value	$ 1.3	$ 2.9	$ 1.3

XML

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013		Dec. 31, 2012
Current assets
Cash and cash equivalents	$ 88,561		$ 118,745
Restricted cash	21,619		27,630
Accounts receivable, net of allowance for doubtful accounts (2013 - $8,336; 2012 - $5,947)	81,235		79,401
Receivable from nonconsolidated affiliates	14,369		22,883
Prepaids and other current assets	22,203		14,415
Current assets related to discontinued operations	312		1,399
Total current assets	228,299		264,473
Property and equipment, net of accumulated depreciation	183,687		179,922
Goodwill	701,971		706,495
Intangible assets, net of accumulated amortization	50,926		48,091
Deferred debt issue costs	10,838		11,131
Investment in and advances to nonconsolidated affiliates	180,618		194,299
Other long-term assets	4,536		2,268
Assets related to discontinued operations	2,128		2,497
Total assets	1,363,003	[1]	1,409,176	[1]
Current liabilities
Current portion of long-term debt	21,711		15,220
Accounts payable	22,911		23,404
Accrued payroll	30,432		19,080
Accrued interest	3,595		13,709
Accrued distributions	24,565		24,805
Payable to nonconsolidated affiliates	65,085		58,926
Deferred income tax liability	639		580
Other current liabilities	18,563		17,598
Current liabilities related to discontinued operations	298		456
Total current liabilities	187,799		173,778
Long-term debt, net of current portion	789,202		774,516
Deferred income tax liability	110,975		100,708
Other long-term liabilities	23,111		21,191
Liabilities related to discontinued operations	403		397
Total liabilities	1,111,490	[1]	1,070,590	[1]
Commitments and contingent liabilities (Note 13)
Noncontrolling interests - redeemable (Note 7)	22,723		21,709
Surgical Care Affiliates' equity
Contributed capital	237,816		310,019
Accumulated other comprehensive loss			(8,327)
Accumulated deficit	(181,216)		(157,309)
Total Surgical Care Affiliates' equity	56,600		144,383
Noncontrolling interests - non-redeemable (Note 7)	172,190		172,494
Total equity	228,790		316,877
Total liabilities and equity	$ 1,363,003		$ 1,409,176

[1] Our consolidated assets as of September 30, 2013 and December 31, 2012 include total assets of a variable interest entity ("VIE") of $44.0 million and $30.2 million, respectively, which can only be used to settle the obligations of the VIE. Our consolidated total liabilities as of September 30, 2013 and December 31, 2012 include total liabilities of the VIE of $8.1 million and $1.4 million, respectively, for which the creditors of the VIE have no recourse to us. See further description in Note 3, Summary of Significant Accounting Policies.

XML

Noncontrolling Interests - Changes in Ownership Interest in Subsidiaries (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Noncontrolling Interest [Abstract]
Net loss attributable to Surgical Care Affiliates	$ (12,708)	$ (2,992)	$ (23,907)	$ (13,249)
Decrease in equity due to sales to noncontrolling interests	(607)	(2,214)	(684)	(4,664)
(Decrease) increase in equity due to purchases from noncontrolling interests	974	(173)	1,065	1,063
Change from net loss attributable to Surgical Care Affiliates and transfers to /from noncontrolling interests	$ (12,341)	$ (5,379)	$ (23,526)	$ (16,850)

XML

Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Summary of Long-Term Debt Outstanding

Our long-term debt outstanding consists of the following:

	As of
	September 30, 2013			December 31, 2012
Bonds payable
Class B Term Loan due 2017		214,980			216,634
Class C Term Loan due 2018		389,025			—
Discount of Class C Term Loan		(901	)		—
Class A Term Loan due 2014		—			118,970
Incremental Term Loan due 2018		—			98,500
Discount of Incremental Term Loan		—			(786	)
10.0% Senior Subordinated Notes due 2017		150,000			150,000
8.875% Senior PIK-election Notes due 2015		—			164,785
Notes payable to banks and others		38,880			24,338
Capital lease obligations		18,929			17,295
		810,913			789,736
Less: Current portion		(21,711	)		(15,220	)
Long-term debt, net of current portion	$	789,202		$	774,516

Summary of Applicable Margin for Each Portion of Credit Facility

The below table outlines the applicable margin for each portion of the Credit Facility.

Facility	Applicable Margin (per annum)
	Base Rate Borrowings	LIBOR Borrowings
Class B Revolving Credit Facility	2.50%	3.50%
Class B Term Loan	3.00%	4.00%
Class C Term Loan	2.00% or 2.25% (with a base rate floor of 2.00%) depending upon the total leverage ratio	3.00% or 3.25% (with a LIBOR floor of 1.00%) depending upon the total leverage ratio

Summary of Changes in Components of Accumulated Other Comprehensive Loss, Net of Related Income Tax Effects

The following table presents changes in the components of Accumulated other comprehensive loss, net of related income tax effects:

	NINE-MONTHS ENDED SEPTEMBER  30, 2013
Balance at Beginning of Period	$	(8,327	)
Other comprehensive income before reclassifications		847
Amounts reclassified from accumulated other comprehensive loss		7,480
Balance at End of Period	$	—

XML

Description of Business (Policies)

9 Months Ended

Sep. 30, 2013

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The Company maintains its books and records on the accrual basis of accounting, and the accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), the instructions for Form 10-Q, Article 10 of Regulation S-X as promulgated by the Securities and Exchange Commission (the “SEC”) and the SEC’s regulations for interim financial information. Such financial statements include the assets, liabilities, revenues and expenses of all wholly-owned subsidiaries, subsidiaries over which we exercise control and, when applicable, affiliates in which we have a controlling financial interest. These interim financial statements do not include all of the disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited financial statements of the Company reflect all adjustments (consisting only of normal, recurring items) necessary for a fair statement of the results for the interim periods presented. Operating results for the three- and nine-month periods ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year-ended December 31, 2013. The accompanying unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company’s audited December 31, 2012 consolidated financial statements included in our final Prospectus filed with the SEC on October 30, 2013 pursuant to Rule 424(b).

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of the Company, its subsidiaries and VIEs for which we are the primary beneficiary. All significant intercompany transactions and accounts have been eliminated.

We evaluate partially owned subsidiaries and joint ventures held in partnership form using authoritative guidance, which includes a framework for evaluating whether a general partner(s) or managing member(s) controls an affiliate and therefore should consolidate it. The framework includes the presumption that general partner or managing member control would be overcome only when the limited partners or members have certain rights. Such rights include the right to dissolve or liquidate the LP, limited liability partnership (“LLP”) or LLC or otherwise remove the general partner or managing member “without cause,” or the right to effectively participate in significant decisions made in the ordinary course of business of the LP, LLP or LLC. To the extent that any noncontrolling investor has rights that inhibit our ability to control the affiliate, including substantive veto rights, we do not consolidate the affiliate.

We use the equity method to account for our investments in affiliates with respect to which we do not have control rights but have the ability to exercise significant influence over operating and financial policies. Assets, liabilities, revenues and expenses are reported in the respective detailed line items on the consolidated financial statements for our consolidated affiliates. For our equity method affiliates, assets and liabilities are reported on a net basis in Investment in and advances to nonconsolidated affiliates on the consolidated balance sheets, and revenues and expenses are reported on a net basis in Equity in net income of nonconsolidated affiliates on the condensed consolidated statements of operations. This difference in accounting treatment of equity method affiliates impacts certain financial ratios of the Company.

Variable Interest Entities

Variable Interest Entities

In order to determine if we are the primary beneficiary of a VIE for financial reporting purposes, we consider whether we have the power to direct the activities of the VIE that most significantly impact the economic performance of the VIE and whether we have the obligation to absorb losses or the right to receive returns that would be significant to the VIE. We consolidate a VIE when we are the primary beneficiary.

In 2012, the Company entered into a transaction whereby we transferred our interest in two consolidated facilities and cash to an entity (the “future JV”) wholly owned by a health system in exchange for a promissory note. Concurrently, the health system transferred its interest in a facility it controlled to the future JV. The promissory note, which eliminates upon consolidation, has a fixed interest rate plus a variable component dependent on the earnings of the future JV. The promissory note contains a conversion feature that allows us to convert the promissory note to a 49% equity interest in the future JV at our option upon the occurrence of the renegotiation of certain contractual arrangements. We also entered into management services agreements with the facilities controlled by the future JV. As a result of the financial interest in the earnings of the future JV held by us via the promissory note and the powers granted us in the promissory note and the management services agreements, we have determined that the future JV is a VIE for which we are the primary beneficiary. We consolidated the future JV as of October 1, 2012.

The carrying amounts and classifications of the assets and liabilities of the future JV, which are included in our September 30, 2013 and December 31, 2012 consolidated balance sheets, were as follows:

	SEPTEMBER 30, 2013		DECEMBER 31, 2012
Assets
Current assets
Accounts receivable, net	$	3,767	$	1,867
Other current assets		9,613		4,635
Total current assets		13,380		6,502
Property and equipment, net		12,630		5,630
Goodwill		12,831		12,265
Intangible assets		5,205		5,792
Total assets	$	44,046	$	30,189
Liabilities
Current liabilities
Accounts payable and other current liabilities	$	4,357	$	1,348
Total current liabilities		4,357		1,348
Other long-term liabilities		3,775		88
Total liabilities	$	8,132	$	1,436

The assets of the consolidated VIE can only be used to settle the obligations of the VIE. The creditors of the VIE have no recourse to us.

Investment in and Advances to Nonconsolidated Affiliates

Investment in and Advances to Nonconsolidated Affiliates

Investments in entities we do not control, but in which we have the ability to exercise significant influence over the operating and financial policies of the investee, are accounted for under the equity method. Equity method investments are recorded at original cost and adjusted periodically to recognize our proportionate share of the investees’ net income or losses after the date of investment, additional contributions made and distributions received, amortization of definite lived intangible assets attributable to equity method investments and impairment losses resulting from adjustments to the carrying value of the investment. We record equity method losses in excess of the carrying amount of an investment when we guarantee obligations or we are otherwise committed to provide further financial support to the affiliate.

Reclassifications and Revisions

Reclassifications and Revisions

Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. Such reclassifications primarily relate to facilities we closed or sold, which qualify for reporting as discontinued operations.

During the third quarter of 2013, we recorded an adjustment increasing Interest expense by approximately $2.2 million related to the correction of an under-accrual of Interest expense during the second quarter of 2013. We do not believe this adjustment is material to either our current period financial statements or our previously issued financial statements.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Earnings Per Share (EPS)

Earnings Per Share (EPS)

We report two earnings per share numbers, basic and diluted. These are computed by dividing net earnings by the weighted-average common shares outstanding (basic EPS) or weighted-average common shares outstanding assuming dilution (diluted EPS), as set forth below:

	THREE-MONTHS ENDED SEPTEMBER 30,				NINE-MONTHS ENDED SEPTEMBER 30,
In thousands	2013		2012		2013		2012
Weighted average shares outstanding		30,353		30,343		30,347		30,338
Dilutive effect of equity-based compensation plans		—		—		—		—
Weighted average shares outstanding, assuming dilution		30,353		30,343		30,347		30,338

The shares used reflect the conversion to a Delaware corporation discussed in Note 1 for all periods. All dilutive share equivalents are reflected in our earnings per share calculations. Antidilutive share equivalents are not included in our EPS calculations. In periods of loss, shares that otherwise would have been included in our diluted weighted-average shares outstanding computation are excluded. The excluded shares for the three-months ended September 30 are as follows: 2013 — 989,000 and 2012 — 354,000. The excluded shares for the nine-months ended September 30 are as follows: 2013 — 686,000 and 2012 — 339,000.

Reportable Segments

Reportable Segments

We have four operating segments, which combine into one reportable segment. Our four operating segments are generally organized geographically. For reporting purposes, we have combined our operating segments into one reportable segment as the nature of the services are similar and the businesses exhibit similar economic characteristics, processes, types and classes of customers, methods of service delivery and distribution and regulatory environments.

Distribution

Distribution

On September 16, 2013, we declared a cash distribution of approximately $0.24 per outstanding membership unit, resulting in a total distribution to our membership unit holders of $74.9 million. The distribution was payable promptly after the date it was declared. In addition, on September 16, 2013, the board of directors of SCA resolved to pay a cash bonus to eligible holders of vested options and restricted equity units of approximately $0.24 per vested option or restricted equity unit, as applicable, resulting in a total bonus payment of $4.6 million, and to adjust downward the exercise price of any such holder’s unvested options by approximately $0.24 per unvested option. The cash bonus payment was recorded as compensation expense in the third quarter of 2013. In addition, we will record stock compensation expense over the remaining vesting periods related to the adjustment to unvested options.

Recent Revisions to Authoritative Guidance

Recent Revisions to Authoritative Guidance

In February 2013, the Financial Accounting Standards Board issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income. This update requires companies to include reclassification adjustments for items that are reclassified from other comprehensive income to net income in a single note or on the face of the financial statements. The amendment was effective for annual and interim reporting periods beginning after December 15, 2012. The adoption of this standard did not have a material impact on the consolidated financial statements of the Company.

We do not believe any other recently issued, but not yet effective, revisions to authoritative guidance will have a material effect on our condensed consolidated financial position, results of operations or cash flows.

XML

Results of Operations of Nonconsolidated Affiliates - Additional Information (Detail) (Equity Method Affiliates [Member], USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Equity Method Affiliates [Member]
Schedule of Equity Method Investments [Line Items]
Amortization expense for definite-lived intangible assets attributable to equity method investments	$ 7.9	$ 5.1	$ 17.9	$ 15.2

XML

Fair Value of Financial Instruments - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended	9 Months Ended		1 Months Ended	9 Months Ended
	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Jun. 30, 2013 Health Inventures, LLC [Member]	Sep. 30, 2013 Health Inventures, LLC [Member]	Sep. 30, 2013 Interest Rate Swaps [Member]	Dec. 31, 2012 Interest Rate Swaps [Member]
Fair Value Inputs, Equity, Quantitative Information [Line Items]
Fair value related to non-performance risk							$ 0.1	$ 0.1
Consideration placed into escrow					8.9	8.9
Contingent consideration recognized					7.2	7.2
Impairment charge on investment in nonconsolidated affiliate	1.2	1.5	1.2
Impairment charge				$ 0.4

XML

Equity-Based Compensation - Schedule of Share-Based Activity (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-based compensation expense	$ 1,664	$ 459	$ 2,093	$ 1,260

XML

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $) In Millions, except Share data, unless otherwise specified	0 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 16, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 Segment	Sep. 30, 2012	Dec. 31, 2012
Accounting Policies [Abstract]
Percentage of convert the promissory note to equity interest						49.00%
Increase in interest expense		$ 2.2
Antidilutive shares excluded from diluted weighted average units outstanding computation		989,000	354,000	686,000	339,000
Operating segments				4
Reportable segment				1
Cash distribution declared date	Sep. 16, 2013
Cash distribution per outstanding membership unit	$ 0.24
Cash distribution to membership unit holders	74.9
Cash bonus per vested option	0.24
Total bonus payment	$ 4.6
Reduction in exercise price of unvested option	$ 0.24

XML

Description of Business - Summary of Business Structure (Detail)	9 Months Ended
	Sep. 30, 2013 Facilities
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Consolidated facilities	86
Equity method facilities	61
Managed only facilities	27
Total facilities	174

XML

Transactions, Deconsolidations and Closures - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended					1 Months Ended	9 Months Ended
	Apr. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 Deconsolidations, Closures and Sale [Member] Transactions Facilities	Sep. 30, 2012 Deconsolidations, Closures and Sale [Member] Facilities Transactions	Sep. 30, 2012 Deconsolidations, Closures and Sale [Member] ASC [Member] Center	Jun. 30, 2013 Health Inventures, LLC [Member] Facilities	Sep. 30, 2013 Health Inventures, LLC [Member]
Business Combinations Discontinued Operations And Related Transactions [Line Items]
Total consideration	$ 4,000,000								$ 18,500,000
Acquisition of interest									100.00%
Payment of cash									9,600,000
Contingent consideration									8,900,000	8,900,000
Undiscounted range of amounts, low									0
Undiscounted range of amounts, high									8,900,000
Contingent consideration recognized as of date									7,200,000	7,200,000
Number of acquired affiliated facilities									19
Number of deconsolidation transactions						2	1
Cash proceeds from sale of investments				4,587,000		2,100,000	4,300,000
Loss (gain) on sale of investments		(75,000)		(1,060,000)	2,001,000	1,600,000	2,000,000
Equity in net income of nonconsolidated affiliates		4,105,000	4,890,000	16,111,000	16,676,000	1,500,000
Number of facilities closed						1	2
Income (loss) from discontinued operations, net of income tax expense		(255,000)	1,041,000	(4,237,000)	(4,113,000)	(1,500,000)	(3,200,000)	1,500,000
Goodwill written off related to closure							$ 2,200,000
Number of Ambulatory Surgery Center Facilities sold								1

XML

Results of Operations of Nonconsolidated Affiliates

9 Months Ended

Sep. 30, 2013

Equity Method Investments And Joint Ventures [Abstract]

Results of Operations of Nonconsolidated Affiliates

NOTE 5 — RESULTS OF OPERATIONS OF NONCONSOLIDATED AFFILIATES

The following summarizes the combined results of operations of our equity method affiliates:

	THREE-MONTHS ENDED SEPTEMBER 30,				NINE-MONTHS ENDED SEPTEMBER 30,
	2013		2012		2013		2012
Net operating revenues:
Net patient revenues	$	152,617	$	113,730	$	415,970	$	345,118
Other revenues		1,326		433		3,763		2,370
Total net operating revenues		153,943		114,163		419,733		347,488
Operating expenses:
Salaries and benefits		34,048		26,770		93,468		81,163
Supplies		26,136		19,064		70,446		57,404
Other operating expenses		30,569		25,202		85,247		73,594
Depreciation and amortization		4,698		3,534		12,544		10,380
Total operating expenses		95,451		74,570		261,705		222,541
Operating income		58,492		39,593		158,028		124,947
Interest expense, net of interest income		516		387		1,185		1,159
Loss on sale of investments		—		—		21		—
Income from continuing operations before income tax expense	$	57,976	$	39,206	$	156,822	$	123,788
Net income	$	57,964	$	39,188	$	156,777	$	123,745

During the three- and nine-months ended September 30, 2013, we recorded $7.9 million and $17.9 million, respectively, of amortization expense for definite-lived intangible assets attributable to equity method investments. During the three- and nine-months ended September 30, 2012, we recorded $5.1 million and $15.2 million, respectively, of amortization expense for definite-lived intangible assets attributable to equity method investments. This expense was included in Equity in net income of nonconsolidated affiliates in our consolidated financial statements.

XML

Fair Value of Financial Instruments - Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments (Detail) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Carrying Amount [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap agreements (includes short-term component)	$ 3,263	$ 6,105
Long-term debt:
Advances under $132.3 million Class B Revolving Credit Facility
Financial commitments
Estimated Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap agreements (includes short-term component)	3,263	6,105
Long-term debt:
Advances under $132.3 million Class B Revolving Credit Facility
Financial commitments
Class A Term Loan due 2014 [Member] | Carrying Amount [Member]
Long-term debt:
Term Loan		118,970
Class A Term Loan due 2014 [Member] | Estimated Fair Value [Member]
Long-term debt:
Term Loan		118,673
Class B Term Loan due 2017 [Member] | Carrying Amount [Member]
Long-term debt:
Term Loan	214,980	216,634
Class B Term Loan due 2017 [Member] | Estimated Fair Value [Member]
Long-term debt:
Term Loan	214,980	215,280
Class C Term Loan due 2018 [Member] | Carrying Amount [Member]
Long-term debt:
Term Loan	389,025
Class C Term Loan due 2018 [Member] | Estimated Fair Value [Member]
Long-term debt:
Term Loan	386,350
Incremental Term Loan due 2018 [Member] | Carrying Amount [Member]
Long-term debt:
Term Loan		98,500
Incremental Term Loan due 2018 [Member] | Estimated Fair Value [Member]
Long-term debt:
Term Loan		98,500
8.875%/9.625% Senior PIK-Election Notes due 2015 [Member] | Carrying Amount [Member]
Long-term debt:
Notes payable		164,785
8.875%/9.625% Senior PIK-Election Notes due 2015 [Member] | Estimated Fair Value [Member]
Long-term debt:
Notes payable		167,119
10% Senior Subordinated Notes due 2017 [Member] | Carrying Amount [Member]
Long-term debt:
Notes payable	150,000	150,000
10% Senior Subordinated Notes due 2017 [Member] | Estimated Fair Value [Member]
Long-term debt:
Notes payable	155,719	157,313
Notes Payable to Banks and Others [Member] | Carrying Amount [Member]
Long-term debt:
Notes payable	38,880	24,338
Notes Payable to Banks and Others [Member] | Estimated Fair Value [Member]
Long-term debt:
Notes payable	$ 38,880	$ 24,338

XML

Noncontrolling Interests (Tables)

9 Months Ended

Sep. 30, 2013

Noncontrolling Interest [Abstract]

Breakout of Net Income (Loss) Between Continuing and Discontinued Operations

The following table shows the breakout of net income (loss) attributable to Surgical Care Affiliates between continuing operations and discontinued operations:

	THREE-MONTHS ENDED SEPTEMBER 30,						NINE-MONTHS ENDED SEPTEMBER 30,
	2013			2012			2013			2012
Net loss from continuing operations, net of tax, attributable to Surgical Care Affiliates	$	(12,453	)	$	(4,033	)	$	(19,670	)	$	(9,136	)
Net (loss) income from discontinued operations, net of tax, attributable to Surgical Care Affiliates		(255	)		1,041			(4,237	)		(4,113	)
Net loss, net of tax, attributable to Surgical Care Affiliates	$	(12,708	)	$	(2,992	)	$	(23,907	)	$	(13,249	)

Changes in Ownership Interest in Subsidiaries

The following table shows the effects of changes to Surgical Care Affiliates’ ownership interest in its subsidiaries on Surgical Care Affiliates’ equity:

	THREE-MONTHS ENDED SEPTEMBER 30,						NINE-MONTHS ENDED SEPTEMBER 30,
	2013			2012			2013			2012
Net loss attributable to Surgical Care Affiliates	$	(12,708	)	$	(2,992	)	$	(23,907	)	$	(13,249	)
Decrease in equity due to sales to noncontrolling interests		(607	)		(2,214	)		(684	)		(4,664	)
(Decrease) increase in equity due to purchases from noncontrolling interests		974			(173	)		1,065			1,063
Change from net loss attributable to Surgical Care Affiliates and transfers to /from noncontrolling interests	$	(12,341	)	$	(5,379	)	$	(23,526	)	$	(16,850	)

Schedule of Redeemable Noncontrolling Interests

The activity relating to the Company’s noncontrolling interests—redeemable is summarized below:

	NINE-MONTHS ENDED SEPTEMBER 30,
	2013			2012
Balance at Beginning of Period	$	21,709		$	20,215
Net income attributable to noncontrolling interests		20,279			18,281
Net change related to purchase of ownership interests		280			309
Contributions from noncontrolling interests		1,004			—
Change in distribution accrual		(16	)		(306	)
Distributions to noncontrolling interests		(20,533	)		(17,318	)
Balance at End of Period	$	22,723		$	21,181

XML

Goodwill - Schedule of Changes in Carrying Amount of Goodwill (Detail) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Apr. 30, 2013
Goodwill And Intangible Assets Disclosure [Abstract]
Beginning balance	$ 706,495	$ 679
Acquisitions (see Note 2)	2,983
Deconsolidation (see Note 2)	(7,351)
Other	(156)
Ending balance	$ 701,971	$ 679

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2013

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

NOTE 8 — FAIR VALUE OF FINANCIAL INSTRUMENTS

The Company follows the provisions of the authoritative guidance for fair value measurements, which addresses how companies should measure fair value when they are required to use a fair value measure for recognition or disclosure purposes under generally accepted accounting principles.

The fair value of an asset or liability is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. As a basis for considering assumptions, the authoritative guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

• Level 1 – Observable inputs such as quoted prices in active markets;

• Level 2 – Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

• Level 3 – Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Assets and liabilities measured at fair value are based on one or more of three valuation techniques, as follows:

• Market approach – Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities;

• Cost approach – Amount that would be required to replace the service capacity of an asset (i.e., replacement cost); and

• Income approach – Techniques to convert future amounts to a single present amount based on market expectations (including present value techniques, option-pricing models, and lattice models).

The fair values of our assets and liabilities that are measured on a recurring basis are as follows (in millions):

	September 30, 2013
	Fair Value Measurements Using						Total Assets/Liabilities at Fair Value		Valuation Technique1
	Level 1		Level 2		Level 3
Assets
Other long-term assets	$	—	$	—	$	1.7	$	1.7	I
Total assets	$	—	$	—	$	1.7	$	1.7
Liabilities
Other current liabilities	$	—	$	—	$	—	$	—	I
Other long-term liabilities		—		3.3	$	—		3.3	I
Total liabilities	$	—	$	3.3	$	—	$	3.3

	December 31, 2012
	Fair Value Measurements Using								Valuation
	Level 1		Level 2		Level 3		Total		Technique1
Liabilities
Other current liabilities	$	—	$	2.2	$	—	$	2.2	I
Other long-term liabilities		—		3.9	$	—		3.9	I
Total liabilities	$	—	$	6.1	$	—	$	6.1

¹  As discussed above, the authoritative guidance identifies three valuation techniques: market approach (M), cost approach (C), and income approach (I).

Interest Rate Swaps

On a recurring basis, we measure our interest rate swaps at fair value. The fair value of our interest rate swaps is derived from models based upon well recognized financial principles and reasonable estimates about relevant future market conditions and calculations of the present value of future cash flows, discounted using market rates of interest. Further, included in the fair value is approximately $0.1 million related to non-performance risk associated with the interest rate swaps at September 30, 2013 and December 31, 2012.

Contingent Consideration

As further described in Note 2, $8.9 million of the HI consideration was placed into escrow as contingent consideration. The amount payable as contingent consideration depends upon the successful continuation and/or renewal of certain management agreement contracts held by HI and, in the case of renewals, will be determined by comparing the contract revenue prior to renewal against the expected contract revenue after renewal. As of the acquisition date, approximately $7.2 million of contingent consideration was recognized. There were no changes in the recognized amount of contingent consideration or the undiscounted range of amounts that could be paid as contingent consideration from the acquisition date to September 30, 2013.

Level 3 Disclosures for Recurring Measurements

The following table provides quantitative information associated with the fair value measurement of our recurring Level 3 inputs (in millions):

Level 3 Contingent Consideration	Level 3 Assets as of September 30, 2013	Significant Unobservable Input		Range of Inputs	Weighted Average
Income Approach	$ 1.7	Probabilities of retention of management contracts	(a)	10% - 100%	80%

(a) The fair value of adjustment to the contingent consideration is based on a formula driven threshold contract value set at the time of the HI transaction. The threshold contract value is a function of revenue and probability of retention of each contract over 12 to 18 months from the transaction date. Significant increases or decreases in any of the probabilities of renewal would result in a significantly lower or higher fair value measurement, respectively.

The following table provides a roll-forward of the recurring fair value balance that used Level 3 inputs (in millions):

	Contingent Consideration
Beginning balance as of December 31, 2012	$	—
Addition of contingent consideration asset		1.7
Ending balance as of September 30, 2013	$	1.7

Nonrecurring Measurements

Where applicable, on a nonrecurring basis, we measure property and equipment, goodwill, other intangible assets, investments in nonconsolidated affiliates and assets and liabilities of discontinued operations at fair value. The fair values of our property and equipment and other intangible assets are determined using discounted cash flows and significant unobservable inputs. The fair value of our investments in nonconsolidated affiliates is determined using discounted cash flows or earnings, or market multiples derived from a set of comparables. The fair value of our assets and liabilities of discontinued operations is determined using discounted cash flows and significant unobservable inputs unless there is an offer to purchase such assets and liabilities, which would be the basis for determining fair value. The fair value of our goodwill is determined using discounted cash flows, and, when available and as appropriate, we use comparative market multiples to corroborate discounted cash flow results. Goodwill is tested for impairment as of October 1 of each year, absent any interim impairment indicators.

An impairment charge of $1.5 million was recorded during the nine-months ended September 30, 2013 for an investment in a nonconsolidated affiliate. In conjunction with the deconsolidation of this affiliate (as described in Note 2), we adjusted the investment to fair value. The fair value of the investment in the nonconsolidated affiliate was determined based on the estimated fair value using valuations techniques that included recent market transactions

Also during the three- and nine- months ended September 30, 2013 an impairment charge of $1.2 million was recorded for an investment in a nonconsolidated affiliate due to the decline of future cash flows of such nonconsolidated affiliate that we judged to be other than temporary. This impairment is included in Equity in net income of nonconsolidated affiliates.

The investment in nonconsolidated affiliate measured at fair value on a nonrecurring basis is as follows (in millions of U.S. dollars):

			Fair Value Measurements Using
September 30, 2013	Net Carrying Value as of:		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses Year-ended:
Investment in nonconsolidated affiliate	$	1.3		—		—	$	1.3	$	1.2
June 30, 2013	Net Carrying Value as of:		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses Year-ended:
Investment in nonconsolidated affiliate	$	2.9		—		—	$	2.9	$	1.5

The inputs used by the Company in estimating the value of Level 3 Investment in nonconsolidated affiliate may include the weighted average cost of capital (“WACC”), revenue growth rates and exit price. Assumptions used by the Company due to the lack of observable inputs may significantly impact the resulting fair value and therefore the Company’s results of operations. The following table includes information regarding the significant unobservable input used in the estimation of Level 3 fair value measurement.

Level 3 Investment in nonconsolidated affiliate	Level 3 Assets as of September 30, 2013	Significant Unobservable Inputs	Range of Inputs
Income Approach	$ 1.3	WACC	11.4%
		Revenue growth rates	2.9% - 5.7%

Level 3 Investment in nonconsolidated affiliate	Level 3 Assets as of June 30, 2013	Significant Unobservable Input			Range of Inputs
Market Approach	$2.9	Exit price	(a	)	$2.9

(a) The exit price was determined using the amount stated in a firm offer letter for the investment.

An impairment charge of $0.4 million was recorded during the nine-months ended September 30, 2012 for intangible and long-lived assets. Facilities experiencing declining trends of earnings from operations or triggering events, such as the loss of significant case volume or increased local competition, resulted in the impairment charge recorded in 2012. No impairment charges for property and equipment were recorded during the three- and nine- months ended September 30, 2013. The fair value of the impaired long-lived assets was determined based on the assets’ estimated fair value using valuations techniques that included third-party appraisals.

Property and equipment measured at fair value on a nonrecurring basis are as follows (in millions of U.S. dollars):

			Fair Value Measurements Using
March 31, 2012	Net Carrying Value as of:		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses Year-ended:
Property and equipment	$	0.9		—		—	$	0.9	$	0.4

The inputs used by the Company in estimating the value of Level 3 Property and equipment include the replacement cost per square foot, depreciation percentage and market price per square foot. Assumptions used by the Company due to the lack of observable inputs may significantly impact the resulting fair value and therefore the Company’s results of operations. The following table includes information regarding significant unobservable inputs used in the estimation of Level 3 fair value measurement.

Level 3 Property and equipment	Level 3 Assets as of March 31, 2012		Significant Unobservable Input			Range of Inputs		Weighted Average
Market Approach	$	0.9	Price per square foot	(a	)	$	109	$	109

(a) Price per square foot is multiplied times the total square footage of a facility to determine the approximate market value.

The following table presents the carrying amounts and estimated fair values of our financial instruments that are classified as long-term liabilities in our condensed consolidated balance sheets (in thousands). The carrying value equals fair value for our financial instruments that are classified as current in our condensed consolidated balance sheets. The carrying amounts of a portion of our long-term debt approximate fair value due to various characteristics of those issues, including short-term maturities, call features and rates that are reflective of current market rates. For our long-term debt without such characteristics, we determined the fair market value by using quoted market prices, when available, or discounted cash flows to calculate their fair values. The fair values utilize inputs other than quoted prices in active markets, although the inputs are observable either directly or indirectly; accordingly, the fair values are in level 2 of the fair value hierarchy.

	As of September 30, 2013				As of December 31, 2012
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Interest rate swap agreements (includes short-term component)	$	3,263	$	3,263	$	6,105	$	6,105
Long-term debt:
Advances under $132.3 million Class B Revolving Credit Facility	$	—	$	—	$	—	$	—
Class A Term Loan due 2014		—		—		118,970		118,673
Class B Term Loan due 2017		214,980		214,980		216,634		215,280
Class C Term Loan due 2018		389,025		386,350		—		—
Incremental Term Loan due 2018		—		—		98,500		98,500
8.875%/9.625% Senior PIK-Election Notes due 2015		—		—		164,785		167,119
10% Senior Subordinated Notes due 2017		150,000		155,719		150,000		157,313
Notes payable to banks and others		38,880		38,880		24,338		24,338
Financial commitments	$	—	$	—	$	—	$	—

XML

Goodwill

9 Months Ended

Sep. 30, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill

NOTE 4 — GOODWILL

Goodwill represents the unallocated excess of purchase price over the fair value of identifiable assets and liabilities acquired in business combinations. Goodwill also includes the unallocated excess of purchase price plus the fair value of any noncontrolling interest in the acquiree at the acquisition date over the fair value of identifiable assets and liabilities acquired in business combinations. The following table shows changes in the carrying amount of goodwill for the nine-months ended September 30, 2013:

Balance at December 31, 2012	$	706,495
Acquisitions (see Note 2)		2,983
Deconsolidation (see Note 2)		(7,351	)
Other		(156	)
Balance at September 30, 2013	$	701,971

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities
Net income	$ 50,953	$ 55,611
Loss from discontinued operations	4,237	4,113
Adjustments to reconcile net income to net cash provided by operating activities
Provision for doubtful accounts	10,364	10,291
Depreciation and amortization	31,928	30,414
Amortization of deferred issuance costs	2,908	2,235
Impairment of long-lived assets		434
Realized loss (gain) on sale of investments	1,060	(2,001)
Loss (gain) on disposal of assets	339	(186)
Equity in net income of nonconsolidated affiliates	(16,111)	(16,676)
Distributions from nonconsolidated affiliates	38,662	30,142
Deferred income tax	10,326	8,884
Stock compensation	2,093	1,260
Loss on de-designation and change in fair value of interest rate swap	8,140
Loss on extinguishment of debt	3,800
Payment of deferred interest	(14,785)
(Increase) decrease in assets, net of business combinations
Accounts receivable	(11,278)	(8,043)
Other assets	2,745	(8,549)
(Decrease) increase in liabilities, net of business combinations
Accounts payable	(615)	(2,398)
Accrued payroll	10,609	614
Accrued interest	(10,114)	(7,892)
Other liabilities	11,186	25,568
Other, net	(4,189)	1,836
Net cash used in operating activities of discontinued operations	(1,499)	(3,722)
Net cash provided by operating activities	130,759	121,935
Cash flows from investing activities
Capital expenditures	(26,248)	(20,786)
Proceeds from disposal of assets	1,673	3,006
Proceed from sale of business		2,795
Proceeds from sale of equity interests of nonconsolidated affiliates	4,587
Proceeds from sale of equity interests of consolidated affiliates in deconsolidation transactions	2,069	4,250
Decrease in cash related to conversion of consolidated affiliates to equity interests	(116)	(763)
Increase in cash related to conversion of equity method affiliates to consolidated affiliates		50
Net change in restricted cash	5,298	2,009
Net settlements on interest rate swap	(2,529)	(5,291)
Business acquisitions, net of cash acquired $1,179	(21,321)
Purchase of equity interests in nonconsolidated affiliates	(150)	(3,302)
Net cash provided by investing activities of discontinued operations	13	212
Net cash used in investing activities	(36,724)	(17,820)
Cash flows from financing activities
Borrowings under line of credit arrangements and long term debt, net of issuance costs	410,960	3,442
Payment of debt acquisition costs	(5,700)
Principal payments on line of credit arrangements and long-term debt	(374,465)	(6,271)
Principal payments under capital lease obligations	(5,328)	(4,528)
Distributions to noncontrolling interests of consolidated affiliates	(79,209)	(69,779)
Contributions from noncontrolling interests of consolidated affiliates	2,417
Proceeds from sale of equity interests of consolidated affiliates	4,115	5,727
Repurchase of equity interests of consolidated affiliates	(2,771)	(2,257)
Distributions to unit holders	(74,615)
Other	356
Net cash used in financing activities	(124,240)	(73,666)
Change in cash and cash equivalents	(30,205)	30,449
Cash and cash equivalents at beginning of period	118,745	71,276
Cash and cash equivalents of discontinued operations at beginning of period	51	105
Less: Cash and cash equivalents of discontinued operations at end of period	(30)	(34)
Cash and cash equivalents at end of period	88,561	101,796
Supplemental schedule of noncash investing and financing activities
Property and equipment acquired through capital leases and installment purchases	9,261	5,369
Net investment in consolidated affiliates that became equity method facilities	5,356	901
Noncontrolling interest associated with conversion of consolidated affiliates to equity method affiliates	226	865
Conversion of equity method affiliate to consolidated affiliate financed through the issuance of debt		7,221
Purchase of equity interest in a nonconsolidated affiliate financed via withheld distributions from a separate nonconsolidated affiliate		$ 1,691

XML

Noncontrolling Interests - Schedule of Redeemable Noncontrolling Interests (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Redeemable Noncontrolling Interest [Line Items]
Balance at Beginning of Period			$ 21,709
Net change related to purchase of ownership interests	607	2,214	684	4,664
Contributions from noncontrolling interests			2,417
Change in distribution accrual			255	(300)
Distributions to noncontrolling interests			(58,676)	(52,461)
Balance at End of Period	22,723		22,723
Non-Controlling Interests-Redeemable [Member]
Redeemable Noncontrolling Interest [Line Items]
Balance at Beginning of Period			21,709	20,215
Net income attributable to noncontrolling interests			20,279	18,281
Net change related to purchase of ownership interests			280	309
Contributions from noncontrolling interests			1,004
Change in distribution accrual			(16)	(306)
Distributions to noncontrolling interests			(20,533)	(17,318)
Balance at End of Period	$ 22,723	$ 21,181	$ 22,723	$ 21,181

XML

Long-Term Debt - Additional Information (Detail) (USD $)	9 Months Ended						3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended								3 Months Ended	9 Months Ended				0 Months Ended
	Sep. 30, 2013	Dec. 31, 2012 Other current liabilities [Member]	Sep. 30, 2013 Other long-term liabilities [Member]	Dec. 31, 2012 Other long-term liabilities [Member]	Sep. 30, 2013 Letters of Credit [Member]	Sep. 30, 2013 Senior Secured Credit Facility [Member]	Sep. 30, 2013 Class B Term Loan due 2017 [Member]	Sep. 30, 2013 Class B Term Loan due 2017 [Member]	Dec. 31, 2012 Class B Term Loan due 2017 [Member]	Sep. 30, 2013 Class C Term Loan due 2018 [Member]	Sep. 30, 2013 Class C Term Loan due 2018 [Member]	Sep. 30, 2013 Class C Term Loan due 2018 [Member] Base Rate Borrowings [Member]	Sep. 30, 2013 Class C Term Loan due 2018 [Member] LIBOR Borrowings [Member]	Sep. 30, 2013 10.0% Senior Subordinated Notes due 2017 [Member]	Sep. 30, 2013 Senior Secured Revolving Credit Facility [Member]	Sep. 30, 2013 Senior Secured Revolving Credit Facility [Member] Class B Revolving Credit Facility [Member]	Sep. 30, 2013 Interest Rate Swaps [Member]	Dec. 31, 2012 Interest Rate Swaps [Member]	Sep. 30, 2013 Interest Rate Swaps [Member] Interest Expense [Member]	Sep. 30, 2013 Interest Rate Swaps [Member] Interest Expense [Member]	Sep. 30, 2013 Interest Rate Swaps [Member] Other current liabilities [Member]	Sep. 30, 2013 Interest Rate Swaps [Member] Other long-term liabilities [Member]	Dec. 31, 2012 Class A and Class B Term Loans [Member]	Jun. 14, 2013 Senior PIK-Election Notes due 2015 [Member]
Debt Instrument [Line Items]
Long-term debt						$ 604,000,000	$ 214,980,000	$ 214,980,000	$ 216,634,000	$ 388,100,000	$ 388,100,000			$ 150,000,000									$ 335,600,000
Long-term debt, maturity date								Dec. 30, 2017			Jun. 30, 2018			Jul. 15, 2017		Jun. 30, 2016								Jul. 15, 2015
Long-term debt, fixed interest percentage														10.00%
Long-term debt, extinguishment date																								Jun. 14, 2013
Ownership percentage in subsidiary	100.00%
Long-term debt, interest percentage							4.25%	4.25%		4.25%	4.25%
Debt instrument, face amount										389,025,000	389,025,000
Percentage of repayment of term loan in quarterly installments on maturity date							0.25%			0.25%
Borrowings, description of variable rate basis											The applicable margin for borrowings under the Class C Term Loan is (i) 2.25% with respect to base rate borrowings (with a base rate floor of 2.00%) and (ii) 3.25% with respect to LIBOR borrowings (with a LIBOR floor of 1.00%).				Borrowings under each portion of the Credit Facility bear interest at a base rate or at the London interbank market for the interest period relevant to such borrowings ("LIBOR"), as elected by SCA, plus an applicable margin. The base rate is determined by reference to the higher of (i) the prime rate of JPMorgan Chase Bank, N.A. and (ii) the federal funds effective rate plus 0.50%. The LIBOR rate is determined by reference to the interest rate for dollar deposits in the London interbank market for the interest period relevant to such borrowings. The below table outlines the applicable margin for each portion of the Credit Facility.
Debt instrument, borrowings rate												2.25%	3.25%		0.50%
Remaining borrowing capacity																132,300,000
Maximum borrowing capacity	132,300,000				5,000,000
Letters of credit outstanding					1,700,000
Cash paid for extinguishment of debt											8,700,000
Debt instrument, floor rate												2.00%	1.00%
Loss on extinguishment of debt	(3,800,000)										3,800,000
Derivative notional amount																		240,000,000
Gross liabilities in derivatives fair value		2,200,000	3,300,000	3,900,000
Decrease in liability related to swaps																	(2,800,000)				(2,200,000)	(600,000)
Effect of changes in the fair value of derivative instruments																			$ 500,000	$ 8,100,000

XML

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2013

Discontinued Operations And Disposal Groups [Abstract]

Schedule of Operating Results, Assets and Liabilities Related to Discontinued Operations

The operating results of discontinued operations are as follows:

	THREE-MONTHS ENDED SEPTEMBER 30,						NINE-MONTHS ENDED SEPTEMBER 30,
	2013			2012			2013			2012
Net operating revenues	$	589		$	3,094		$	2,399		$	11,810
Gain (loss) on sale of investments or closures		24			1,351			(2,226	)		(1,858	)
Costs and expenses		(716	)		(3,494	)		(3,772	)		(13,484	)
(Loss) income from discontinued operations		(103	)		951			(3,599	)		(3,532	)
Income tax (expense) benefit		(152	)		90			(638	)		(581	)
Net (loss) income from discontinued operations	$	(255	)	$	1,041		$	(4,237	)	$	(4,113	)

The assets and liabilities related to discontinued operations consist of the following:

	SEPTEMBER 30, 2013		DECEMBER 31, 2012
Assets
Current assets
Accounts receivable, net	$	204	$	1,162
Other current assets		108		237
Total current assets		312		1,399
Property and equipment, net		1,897		2,263
Other long term assets		231		234
Total assets	$	2,440	$	3,896
Liabilities
Current liabilities
Accounts payable and other current liabilities	$	298	$	456
Total current liabilities		298		456
Other long-term liabilities		403		397
Total liabilities	$	701	$	853

XML

Equity-Based Compensation - Summary of Status in Non-Vested Restricted Shares (Detail) (Restricted Stock [Member], USD $)	9 Months Ended
	Sep. 30, 2013
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Non-vested, Beginning Balance	19,712
Number of Shares, granted	51,417
Number of Shares, vested	(16,685)
Number of Shares, Non-vested, Ending Balance	54,444
Weighted Average Grant Price, Non-vested, Beginning Balance	$ 10.63
Weighted Average Grant Price, granted	$ 22.93
Weighted Average Grant Price, vested	$ 10.63
Weighted Average Grant Price, Non-vested, Ending Balance	$ 22.93

XML

Fair Value of Financial Instruments - Schedule of Significant Unobsevable Input Used in Estimation of Level 3 Fair Value Measurement - Investment in Nonconsolidated Affiliate (Detail) (Fair Value, Measurements, Nonrecurring [Member], Significant Unobservable Inputs (Level 3) [Member], USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended	9 Months Ended
	Mar. 31, 2012 Market Approach [Member]	Jun. 30, 2013 Market Approach [Member]	Sep. 30, 2013 Range of Inputs 11.4% [Member] Income Approach [Member]	Sep. 30, 2013 Range of Inputs 2.9%-5.7% [Member] Income Approach [Member]	Jun. 30, 2013 Range of Inputs [Member] Market Approach [Member]	Sep. 30, 2013 Minimum [Member] Range of Inputs 2.9%-5.7% [Member] Income Approach [Member]	Sep. 30, 2013 Maximum [Member] Range of Inputs 2.9%-5.7% [Member] Income Approach [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Investment in nonconsolidated affiliate		$ 2.9	$ 1.3		$ 2.9
Significant Unobservable Input	Price per square foot	Exit price	WACC	Revenue growth rates
Range of Inputs			11.40%			2.90%	5.70%

XML

Discontinued Operations

9 Months Ended

Sep. 30, 2013

Discontinued Operations And Disposal Groups [Abstract]

Discontinued Operations

NOTE 11 — DISCONTINUED OPERATIONS

The Company has closed or sold certain facilities that qualify for reporting as discontinued operations. The assets and liabilities associated with these facilities are reflected in the accompanying condensed consolidated balance sheets as of September 30, 2013 and December 31, 2012 as Current assets related to discontinued operations, Assets related to discontinued operations, Current liabilities related to discontinued operations and Liabilities related to discontinued operations. Additionally, the accompanying condensed consolidated statements of operations and cash flows reflect the loss, net of income tax expense, and the net cash (used in) provided by operating, investing and financing activities, respectively, associated with these facilities as discontinued operations.

The operating results of discontinued operations are as follows:

	THREE-MONTHS ENDED SEPTEMBER 30,						NINE-MONTHS ENDED SEPTEMBER 30,
	2013			2012			2013			2012
Net operating revenues	$	589		$	3,094		$	2,399		$	11,810
Gain (loss) on sale of investments or closures		24			1,351			(2,226	)		(1,858	)
Costs and expenses		(716	)		(3,494	)		(3,772	)		(13,484	)
(Loss) income from discontinued operations		(103	)		951			(3,599	)		(3,532	)
Income tax (expense) benefit		(152	)		90			(638	)		(581	)
Net (loss) income from discontinued operations	$	(255	)	$	1,041		$	(4,237	)	$	(4,113	)

The assets and liabilities related to discontinued operations consist of the following:

	SEPTEMBER 30, 2013		DECEMBER 31, 2012
Assets
Current assets
Accounts receivable, net	$	204	$	1,162
Other current assets		108		237
Total current assets		312		1,399
Property and equipment, net		1,897		2,263
Other long term assets		231		234
Total assets	$	2,440	$	3,896
Liabilities
Current liabilities
Accounts payable and other current liabilities	$	298	$	456
Total current liabilities		298		456
Other long-term liabilities		403		397
Total liabilities	$	701	$	853

XML

Noncontrolling Interests

9 Months Ended

Sep. 30, 2013

Noncontrolling Interest [Abstract]

Noncontrolling Interests

NOTE 7 — NONCONTROLLING INTERESTS

The following table shows the breakout of net income (loss) attributable to Surgical Care Affiliates between continuing operations and discontinued operations:

	THREE-MONTHS ENDED SEPTEMBER 30,						NINE-MONTHS ENDED SEPTEMBER 30,
	2013			2012			2013			2012
Net loss from continuing operations, net of tax, attributable to Surgical Care Affiliates	$	(12,453	)	$	(4,033	)	$	(19,670	)	$	(9,136	)
Net (loss) income from discontinued operations, net of tax, attributable to Surgical Care Affiliates		(255	)		1,041			(4,237	)		(4,113	)
Net loss, net of tax, attributable to Surgical Care Affiliates	$	(12,708	)	$	(2,992	)	$	(23,907	)	$	(13,249	)

The following table shows the effects of changes to Surgical Care Affiliates’ ownership interest in its subsidiaries on Surgical Care Affiliates’ equity:

	THREE-MONTHS ENDED SEPTEMBER 30,						NINE-MONTHS ENDED SEPTEMBER 30,
	2013			2012			2013			2012
Net loss attributable to Surgical Care Affiliates	$	(12,708	)	$	(2,992	)	$	(23,907	)	$	(13,249	)
Decrease in equity due to sales to noncontrolling interests		(607	)		(2,214	)		(684	)		(4,664	)
(Decrease) increase in equity due to purchases from noncontrolling interests		974			(173	)		1,065			1,063
Change from net loss attributable to Surgical Care Affiliates and transfers to /from noncontrolling interests	$	(12,341	)	$	(5,379	)	$	(23,526	)	$	(16,850	)

Certain of the Company’s noncontrolling interests have industry specific redemption features whereby the Company could be obligated, under the terms of certain of its operating subsidiaries’ partnership and operating agreements, to purchase some or all of the noncontrolling interests of the consolidated subsidiaries. As a result, these noncontrolling interests are not included as part of the Company’s equity and are carried as Noncontrolling interests-redeemable on the Company’s condensed consolidated balance sheets.

The activity relating to the Company’s noncontrolling interests—redeemable is summarized below:

	NINE-MONTHS ENDED SEPTEMBER 30,
	2013			2012
Balance at Beginning of Period	$	21,709		$	20,215
Net income attributable to noncontrolling interests		20,279			18,281
Net change related to purchase of ownership interests		280			309
Contributions from noncontrolling interests		1,004			—
Change in distribution accrual		(16	)		(306	)
Distributions to noncontrolling interests		(20,533	)		(17,318	)
Balance at End of Period	$	22,723		$	21,181

XML

Income Taxes - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Tax Disclosure [Abstract]
Current income tax expense attributable to state income taxes	$ 0.2	$ 0.1	$ 0.5	$ 0.3
Deferred income tax expense attributable to tax amortization	$ 5.5	$ 3.9	$ 9.7	$ 8.4

XML

Subsequent Events

9 Months Ended

Sep. 30, 2013

Subsequent Events [Abstract]

Subsequent Events

NOTE 14 — SUBSEQUENT EVENTS

Effective October 1, 2013, we acquired a controlling interest in one ASC located in Melbourne, FL for $0.9 million.

Effective October 1, 2013, through one of our existing health system joint ventures, we acquired a noncontrolling interest in one ASC located in Redding, CA for $1.3 million.

On November 4, 2013, the Company closed its initial public offering of 9,777,778 (1,920,635 were sold by selling shareholders and did not result in proceeds to the Company) shares of its common stock, at a price to the public of $24.00 per share. In connection with the initial public offering, the underwriters exercised in full their option to purchase an additional 1,466,666 shares of common stock from certain of the selling stockholders. As a result, the total initial public offering size was 11,244,444 shares of common stock. Concurrent with the offering, the Company was converted from a Delaware limited liability company, previously named ASC Acquisition LLC, to a Delaware corporation.

On November 4, 2013, SCA and the Co-Issuer issued a notice of redemption communicating its intent to redeem the $150.0 million Senior Subordinated Notes. We expect to redeem the Senior Subordinated Notes on or around December 4, 2013, utilizing proceeds from our initial public offering. We expect the loss on extinguishment relating to the Senior Subordinated Notes to range from $6.5 million to $7.0 million.

In conjunction with the completion of our initial public offering, TPG Capital Management, L.P. is entitled to a fee payable under our management services agreement in an amount equal to $8.0 million. This fee will be paid during the fourth quarter of 2013.

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2013

Related Party Transactions [Abstract]

Related Party Transactions

NOTE 12 — RELATED PARTY TRANSACTIONS

The Company paid management fees to TPG Capital Management, L.P., an affiliate of TPG Global LLC and its affiliates (“TPG”), our majority owner, of $0.5 million and $1.5 million during the three- and nine-months ended September 30, 2013 and 2012, respectively. In connection with the completion of our initial public offering (see Note 14), the Company will no longer pay management fees to TPG Capital Management, L.P. and the related management services agreement has been terminated.

In connection with the amendment of our Amended Credit Agreement on May 8, 2013, TPG Capital BD, LLC, an affiliate of TPG, our majority owner, served as an arranger for purposes of the amendment and was paid an arrangement fee in the amount of $0.5 million during the nine-months ended September 30, 2013. In addition, TPG Capital BD, LLC participated as an underwriter underwriting the shares of our common stock in connection with our initial public offering of common stock and was paid an underwriting discount of approximately $0.7 million by us and the selling stockholders.

Certain directors of the Company have received options to purchase membership units of the Company under the Directors Plan as part of their compensation for service on SCA’s Board and for consulting services provided to the Company. Total expense recognized by the Company related to these options was immaterial for the three- and nine-month periods ended September 30, 2013 and 2012.

The law firm of Bradley Arant Boult Cummings LLP provided certain legal services to us. We paid approximately $0.4 million and $0.3 million to this law firm during the three-months ended September 30, 2013 and 2012, and approximately $1.0 million and $0.6 million during the nine-months ended September 30, 2013 and 2012, respectively, for such legal services. The spouse of one of our executive officers, Richard Sharff, is a partner of this law firm.

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 13, 2013
Document And Entity Information [Abstract]
Document Type	10-Q/A
Amendment Flag	false
Document Period End Date	Sep. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Trading Symbol	SCAI
Entity Registrant Name	Surgical Care Affiliates, Inc.
Entity Central Index Key	0001411574
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		38,142,861

XML

Commitments and Contingent Liabilities

9 Months Ended

Sep. 30, 2013

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingent Liabilities

NOTE 13 — COMMITMENTS AND CONTINGENT LIABILITIES

Legal Proceedings

The Company provides services in a highly regulated industry and is subject to various legal actions and regulatory and other governmental and internal audits and investigations from time to time. As a result, we expect that various lawsuits, claims and legal and regulatory proceedings may be instituted or asserted against us, including, without limitation, employment-related claims and medical negligence claims. Additionally, governmental agencies often possess a great deal of discretion to assess a wide range of monetary penalties and fines. We record accruals for contingencies to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described below because the inherently unpredictable nature of legal proceedings may be exacerbated by various factors, including, but not limited to: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties (including where it is uncertain how liability, if any, will be shared among multiple defendants); or (vii) there is a wide range of potential outcomes. The outcome of any current or future litigation or governmental or internal investigations, cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. Nevertheless, it is reasonably possible that any such penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on our results of operations, financial position and cash flows and may affect our reputation.

On May 5, 2006, Dr. Hansel DeBartolo filed a lawsuit captioned DeBartolo, et al. v. HealthSouth Corporation et al, in the United States District Court for the Northern District of Illinois, Eastern Division, against Joliet Surgery Center Limited Partnership (the “Partnership”), the general partner of that Partnership, Surgicare of Joliet, Inc., and its then-parent, HealthSouth Corporation, for a declaratory judgment and an injunction relating to the forced repurchase of his partnership interest (the “Federal Court Action”). We agreed to take responsibility from HealthSouth Corporation (our parent until SCA was purchased by ASC Acquisition LLC) regarding this matter. Dr. DeBartolo claimed that the partnership agreement’s requirement that an investor in a surgical center perform one-third of his surgical procedures at the center violates the federal Anti-Kickback Statute and its underlying federal policy, and he sought an order prohibiting the repurchase of his partnership interest. After the trial court dismissed the case by holding that no private cause of action exists under the Anti-Kickback Statute, Dr. DeBartolo appealed to the Seventh Circuit Court of Appeals, which directed the trial court to dismiss the case because the Federal courts did not have jurisdiction over the subject matter involved. On February 8, 2010, Dr. DeBartolo filed a lawsuit in the Twelfth Judicial Circuit Court, Will County, Illinois making the same claim and seeking the same relief as he sought in the Federal Court Action. At this time we cannot predict the outcome of this proceeding, but we intend to vigorously defend against Dr. DeBartolo’s claims.

Risk Insurance

Risk insurance for SCA and most of our facilities is provided through SCA’s risk insurance program. We insure a substantial portion of our professional liability, general liability and workers’ compensation risks through low deductible, fully insured programs through unrelated carriers.

Provisions for these risks are based upon market driven premiums and actuarially determined estimates for incurred but not reported exposure under claims made policies. Provisions for losses within the policy deductibles represent the estimated ultimate net cost of all reported and unreported losses incurred through the consolidated balance sheet dates. Those estimates are subject to the effects of trends in loss severity and frequency. While we believe the provisions for losses are adequate, we cannot be sure the ultimate costs will not exceed our estimates.

Leases

We lease certain land, buildings and equipment under non-cancelable operating leases expiring at various dates through 2031. We also lease certain buildings and equipment under capital leases expiring at various dates through 2023. Operating leases generally have 5 to 22 year terms with one or more renewal options and with terms to be negotiated at the time of renewal.

XML

Fair Value of Financial Instruments - Schedule of Significant Unobsevable Input Used in Estimation of Level 3 Fair Value Measurement - Property and Equipment (Detail) (Fair Value, Measurements, Nonrecurring [Member], Market Approach [Member], Significant Unobservable Inputs (Level 3) [Member], USD $)	3 Months Ended	6 Months Ended
	Mar. 31, 2012	Jun. 30, 2013
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Property and equipment	$ 0.9
Level 3 Property and equipment	Price per square foot	Exit price
Property and equipment	109
Range of Inputs [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Property and equipment	109

XML

Fair Value of Financial Instruments - Schedule of Property and Equipment Measured at Fair Value on Nonrecurring Basis (Detail) (USD $)	9 Months Ended			3 Months Ended
	Sep. 30, 2012	Sep. 30, 2013	Dec. 31, 2012	Mar. 31, 2012 Fair Value, Measurements, Nonrecurring [Member]	Mar. 31, 2012 Fair Value, Measurements, Nonrecurring [Member] Significant Unobservable Inputs (Level 3) [Member]
Fair Value Of Assets And Liabilities Measured On Non Recurring Basis [Line Items]
Property and equipment		$ 183,687,000	$ 179,922,000	$ 900,000
Property and Equipment, Net Carrying Value					900,000
Total Losses, Property and equipment	$ 434,000			$ 400,000